ONTOLOGY REPORT - ANNOTATIONS
| Term: | phthalate ester |
|
| Accession: | CHEBI:35484
|
browse the term
|
| Synonyms: | related_synonym: | phthalate esters |
|
|
bis(2-ethylhexyl) phthalate
|
| G |
Abca2 |
ATP-binding cassette, subfamily A (ABC1), member 2 |
|
decreases expression |
ISO |
3 |
3,595,423 |
3,615,328 |
RGD:6480464 |
CTD |
| G |
Abca2 |
ATP-binding cassette, subfamily A (ABC1), member 2 |
|
multiple interactions |
ISO |
3 |
3,595,423 |
3,615,328 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
increases expression |
ISO |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
multiple interactions |
ISO |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
increases expression |
ISO |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
multiple interactions |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases expression |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
multiple interactions |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abhd2 |
abhydrolase domain containing 2 |
|
increases expression |
ISO |
1 |
135,025,144 |
135,111,792 |
RGD:6480464 |
CTD |
| G |
Abhd2 |
abhydrolase domain containing 2 |
|
multiple interactions |
ISO |
1 |
135,025,144 |
135,111,792 |
RGD:6480464 |
CTD |
| G |
Abhd4 |
abhydrolase domain containing 4 |
|
increases expression |
ISO |
15 |
32,312,516 |
32,325,153 |
RGD:6480464 |
CTD |
| G |
Abhd4 |
abhydrolase domain containing 4 |
|
multiple interactions |
ISO |
15 |
32,312,516 |
32,325,153 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
multiple interactions |
ISO |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
increases expression |
ISO |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
increases expression |
ISO |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
multiple interactions |
ISO |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
increases expression |
ISO |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
multiple interactions |
ISO |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Avpr1b |
arginine vasopressin receptor 1B |
|
decreases expression |
EXP |
13 |
44,537,103 |
44,547,318 |
RGD:6480464 |
CTD |
| G |
Bcl3 |
B-cell CLL/lymphoma 3 |
|
multiple interactions |
ISO |
1 |
79,122,801 |
79,137,035 |
RGD:6480464 |
CTD |
| G |
Bdh2 |
3-hydroxybutyrate dehydrogenase, type 2 |
|
decreases expression |
ISO |
2 |
232,765,049 |
232,785,694 |
RGD:6480464 |
CTD |
| G |
Bdh2 |
3-hydroxybutyrate dehydrogenase, type 2 |
|
multiple interactions |
ISO |
2 |
232,765,049 |
232,785,694 |
RGD:6480464 |
CTD |
| G |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
|
increases expression |
ISO |
1 |
82,528,943 |
82,546,606 |
RGD:6480464 |
CTD |
| G |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
|
multiple interactions |
ISO |
1 |
82,528,943 |
82,546,606 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
decreases expression |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bri3bp |
Bri3 binding protein |
|
increases expression |
ISO |
12 |
32,270,907 |
32,282,728 |
RGD:6480464 |
CTD |
| G |
Bri3bp |
Bri3 binding protein |
|
multiple interactions |
ISO |
12 |
32,270,907 |
32,282,728 |
RGD:6480464 |
CTD |
| G |
Bsg |
basigin (Ok blood group) |
|
multiple interactions |
ISO |
7 |
11,507,914 |
11,515,132 |
RGD:6480464 |
CTD |
| G |
Bsg |
basigin (Ok blood group) |
|
increases expression |
ISO |
7 |
11,507,914 |
11,515,132 |
RGD:6480464 |
CTD |
| G |
C1s |
complement component 1, s subcomponent |
|
multiple interactions |
ISO |
4 |
160,736,133 |
160,748,133 |
RGD:6480464 |
CTD |
| G |
C1s |
complement component 1, s subcomponent |
|
decreases expression |
ISO |
4 |
160,736,133 |
160,748,133 |
RGD:6480464 |
CTD |
| G |
C8b |
complement component 8, beta polypeptide |
|
decreases expression |
ISO |
5 |
125,728,606 |
125,766,093 |
RGD:6480464 |
CTD |
| G |
C8b |
complement component 8, beta polypeptide |
|
multiple interactions |
ISO |
5 |
125,728,606 |
125,766,093 |
RGD:6480464 |
CTD |
| G |
Capns1 |
calpain, small subunit 1 |
|
increases expression |
ISO |
1 |
85,519,568 |
85,525,929 |
RGD:6480464 |
CTD |
| G |
Capns1 |
calpain, small subunit 1 |
|
multiple interactions |
ISO |
1 |
85,519,568 |
85,525,929 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbx2 |
chromobox homolog 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cbx2 |
chromobox homolog 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccdc58 |
coiled-coil domain containing 58 |
|
multiple interactions |
ISO |
11 |
66,497,108 |
66,518,067 |
RGD:6480464 |
CTD |
| G |
Ccdc58 |
coiled-coil domain containing 58 |
|
decreases expression |
ISO |
11 |
66,497,108 |
66,518,067 |
RGD:6480464 |
CTD |
| G |
Cd209a |
CD209a molecule |
|
multiple interactions |
ISO |
12 |
2,358,909 |
2,364,492 |
RGD:6480464 |
CTD |
| G |
Cd209a |
CD209a molecule |
|
decreases expression |
ISO |
12 |
2,358,909 |
2,364,492 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
increases expression |
ISO |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
multiple interactions |
ISO |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
increases expression |
EXP |
18 |
8,048,920 |
8,267,974 |
RGD:6480464 |
CTD |
| G |
Cdkl2 |
cyclin-dependent kinase-like 2 (CDC2-related kinase) |
|
increases expression |
ISO |
14 |
17,598,862 |
17,621,559 |
RGD:6480464 |
CTD |
| G |
Cdkl2 |
cyclin-dependent kinase-like 2 (CDC2-related kinase) |
|
multiple interactions |
ISO |
14 |
17,598,862 |
17,621,559 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
decreases expression |
ISO |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Cdv3 |
carnitine deficiency-associated gene expressed in ventricle 3 homolog (mouse) |
|
increases expression |
ISO |
8 |
108,365,896 |
108,376,263 |
RGD:6480464 |
CTD |
| G |
Cdv3 |
carnitine deficiency-associated gene expressed in ventricle 3 homolog (mouse) |
|
multiple interactions |
ISO |
8 |
108,365,896 |
108,376,263 |
RGD:6480464 |
CTD |
| G |
Ces1d |
carboxylesterase 1D |
|
multiple interactions |
ISO |
19 |
14,928,539 |
14,967,082 |
RGD:6480464 |
CTD |
| G |
Ces1d |
carboxylesterase 1D |
|
increases expression |
ISO |
19 |
14,928,539 |
14,967,082 |
RGD:6480464 |
CTD |
| G |
Ces2a |
carboxylesterase 2A |
|
multiple interactions |
ISO |
19 |
37,686 |
44,736 |
RGD:6480464 |
CTD |
| G |
Ces2a |
carboxylesterase 2A |
|
increases expression |
ISO |
19 |
37,686 |
44,736 |
RGD:6480464 |
CTD |
| G |
Ces2c |
carboxylesterase 2C |
|
multiple interactions |
ISO |
1 |
267,887,420 |
267,894,987 |
RGD:6480464 |
CTD |
| G |
Ces2c |
carboxylesterase 2C |
|
increases expression |
ISO |
1 |
267,887,420 |
267,894,987 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a2 |
cytochrome P450, family 4, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
5 |
135,765,673 |
135,773,006 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
increases expression |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
increases expression |
EXP |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
|
multiple interactions |
ISO |
5 |
135,546,858 |
135,578,199 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
multiple interactions |
ISO |
4 |
26,752,677 |
26,771,131 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
increases expression |
ISO |
4 |
26,752,677 |
26,771,131 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp8b1 |
cytochrome P450, family 8, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
127,018,908 |
127,020,878 |
RGD:6480464 |
CTD |
| G |
Cyp8b1 |
cytochrome P450, family 8, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
8 |
127,018,908 |
127,020,878 |
RGD:6480464 |
CTD |
| G |
Dak |
dihydroxyacetone kinase 2 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
1 |
213,081,825 |
213,095,034 |
RGD:6480464 |
CTD |
| G |
Dak |
dihydroxyacetone kinase 2 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
1 |
213,081,825 |
213,095,034 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
decreases expression |
EXP |
3 |
6,052,706 |
6,069,826 |
RGD:6480464 |
CTD |
| G |
Dbi |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dbi |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
|
decreases expression |
ISO |
2 |
212,759,312 |
212,788,180 |
RGD:6480464 |
CTD |
| G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
|
multiple interactions |
ISO |
2 |
212,759,312 |
212,788,180 |
RGD:6480464 |
CTD |
| G |
Dcaf12l1 |
DDB1 and CUL4 associated factor 12-like 1 |
|
increases expression |
ISO |
X |
175,822 |
179,442 |
RGD:6480464 |
CTD |
| G |
Dcaf12l1 |
DDB1 and CUL4 associated factor 12-like 1 |
|
multiple interactions |
ISO |
X |
175,822 |
179,442 |
RGD:6480464 |
CTD |
| G |
Ddx28 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 28 |
|
decreases expression |
ISO |
19 |
35,856,545 |
35,858,475 |
RGD:6480464 |
CTD |
| G |
Ddx28 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 28 |
|
multiple interactions |
ISO |
19 |
35,856,545 |
35,858,475 |
RGD:6480464 |
CTD |
| G |
Dear |
dual endothelin 1, angiotensin II receptor |
|
decreases expression |
EXP |
2 |
176,736,639 |
176,739,891 |
RGD:6480464 |
CTD |
| G |
Decr1 |
2,4-dienoyl CoA reductase 1, mitochondrial |
|
increases expression |
ISO |
5 |
30,492,196 |
30,520,172 |
RGD:6480464 |
CTD |
| G |
Decr1 |
2,4-dienoyl CoA reductase 1, mitochondrial |
|
multiple interactions |
ISO |
5 |
30,492,196 |
30,520,172 |
RGD:6480464 |
CTD |
| G |
Decr2 |
2,4-dienoyl CoA reductase 2, peroxisomal |
|
increases expression |
ISO |
10 |
15,350,593 |
15,358,640 |
RGD:6480464 |
CTD |
| G |
Decr2 |
2,4-dienoyl CoA reductase 2, peroxisomal |
|
multiple interactions |
ISO |
10 |
15,350,593 |
15,358,640 |
RGD:6480464 |
CTD |
| G |
Dhfr |
dihydrofolate reductase |
|
increases expression |
ISO |
2 |
22,607,093 |
22,828,487 |
RGD:6480464 |
CTD |
| G |
Dhfr |
dihydrofolate reductase |
|
multiple interactions |
ISO |
2 |
22,607,093 |
22,828,487 |
RGD:6480464 |
CTD |
| G |
Dhrs4 |
dehydrogenase/reductase (SDR family) member 4 |
|
increases expression |
ISO |
15 |
33,609,570 |
33,621,142 |
RGD:6480464 |
CTD |
| G |
Dhrs4 |
dehydrogenase/reductase (SDR family) member 4 |
|
multiple interactions |
ISO |
15 |
33,609,570 |
33,621,142 |
RGD:6480464 |
CTD |
| G |
Dock6 |
dedicator of cytokinesis 6 |
|
multiple interactions |
ISO |
8 |
20,896,180 |
20,966,159 |
RGD:6480464 |
CTD |
| G |
Dock6 |
dedicator of cytokinesis 6 |
|
increases expression |
ISO |
8 |
20,896,180 |
20,966,159 |
RGD:6480464 |
CTD |
| G |
Dpm3 |
dolichyl-phosphate mannosyltransferase polypeptide 3 |
|
multiple interactions |
ISO |
2 |
181,439,451 |
181,439,966 |
RGD:6480464 |
CTD |
| G |
Dpm3 |
dolichyl-phosphate mannosyltransferase polypeptide 3 |
|
decreases expression |
ISO |
2 |
181,439,451 |
181,439,966 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
decreases expression |
EXP |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Dpy30 |
dpy-30 homolog (C. elegans) |
|
multiple interactions |
ISO |
6 |
21,084,031 |
21,104,731 |
RGD:6480464 |
CTD |
| G |
Dpy30 |
dpy-30 homolog (C. elegans) |
|
increases expression |
ISO |
6 |
21,084,031 |
21,104,731 |
RGD:6480464 |
CTD |
| G |
Fitm2 |
fat storage-inducing transmembrane protein 2 |
|
multiple interactions |
ISO |
3 |
154,375,988 |
154,382,498 |
RGD:6480464 |
CTD |
| G |
Fmc1 |
formation of mitochondrial complexes 1 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
4 |
66,107,930 |
66,115,963 |
RGD:6480464 |
CTD |
| G |
Fmc1 |
formation of mitochondrial complexes 1 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
4 |
66,107,930 |
66,115,963 |
RGD:6480464 |
CTD |
| G |
Folr2 |
folate receptor 2 (fetal) |
|
increases expression |
ISO |
1 |
159,295,773 |
159,314,107 |
RGD:6480464 |
CTD |
| G |
Folr2 |
folate receptor 2 (fetal) |
|
multiple interactions |
ISO |
1 |
159,295,773 |
159,314,107 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxa3 |
forkhead box A3 |
|
decreases expression |
ISO |
1 |
78,368,026 |
78,376,953 |
RGD:6480464 |
CTD |
| G |
Foxp1 |
forkhead box P1 |
|
decreases expression |
ISO |
4 |
133,773,373 |
134,007,018 |
RGD:6480464 |
CTD |
| G |
Foxp1 |
forkhead box P1 |
|
multiple interactions |
ISO |
4 |
133,773,373 |
134,007,018 |
RGD:6480464 |
CTD |
| G |
Foxq1 |
forkhead box Q1 |
|
decreases expression |
ISO |
17 |
39,332,906 |
39,334,655 |
RGD:6480464 |
CTD |
| G |
Foxq1 |
forkhead box Q1 |
|
multiple interactions |
ISO |
17 |
39,332,906 |
39,334,655 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
decreases expression |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1switch 2 |
|
increases expression |
ISO |
13 |
109,121,297 |
109,122,209 |
RGD:6480464 |
CTD |
| G |
G3bp2 |
GTPase activating protein (SH3 domain) binding protein 2 |
|
increases expression |
ISO |
14 |
17,556,967 |
17,588,259 |
RGD:6480464 |
CTD |
| G |
G3bp2 |
GTPase activating protein (SH3 domain) binding protein 2 |
|
multiple interactions |
ISO |
14 |
17,556,967 |
17,588,259 |
RGD:6480464 |
CTD |
| G |
Gad2 |
glutamate decarboxylase 2 |
|
decreases expression |
EXP |
17 |
96,259,430 |
96,321,857 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
increases expression |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Gale |
UDP-galactose-4-epimerase |
|
increases expression |
ISO |
5 |
154,745,853 |
154,750,357 |
RGD:6480464 |
CTD |
| G |
Gale |
UDP-galactose-4-epimerase |
|
multiple interactions |
ISO |
5 |
154,745,853 |
154,750,357 |
RGD:6480464 |
CTD |
| G |
Galr1 |
galanin receptor 1 |
|
decreases expression |
EXP |
18 |
78,858,892 |
78,874,451 |
RGD:6480464 |
CTD |
| G |
Galr2 |
galanin receptor 2 |
|
decreases expression |
EXP |
10 |
106,394,006 |
106,396,171 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
increases expression |
ISO |
16 |
80,900,159 |
80,930,929 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
multiple interactions |
ISO |
16 |
80,900,159 |
80,930,929 |
RGD:6480464 |
CTD |
| G |
Gcgr |
glucagon receptor |
|
decreases expression |
EXP |
10 |
109,921,411 |
109,929,577 |
RGD:6480464 |
CTD |
| G |
Gda |
guanine deaminase |
|
multiple interactions |
ISO |
1 |
224,579,794 |
224,655,298 |
RGD:6480464 |
CTD |
| G |
Gda |
guanine deaminase |
|
increases expression |
ISO |
1 |
224,579,794 |
224,655,298 |
RGD:6480464 |
CTD |
| G |
Gde1 |
glycerophosphodiester phosphodiesterase 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gde1 |
glycerophosphodiester phosphodiesterase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Ghitm |
growth hormone inducible transmembrane protein |
|
increases expression |
ISO |
16 |
13,327,337 |
13,338,420 |
RGD:6480464 |
CTD |
| G |
Ghitm |
growth hormone inducible transmembrane protein |
|
multiple interactions |
ISO |
16 |
13,327,337 |
13,338,420 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja4 |
gap junction protein, alpha 4 |
|
decreases expression |
ISO |
5 |
146,755,061 |
146,757,594 |
RGD:6480464 |
CTD |
| G |
Gja4 |
gap junction protein, alpha 4 |
|
multiple interactions |
ISO |
5 |
146,755,061 |
146,757,594 |
RGD:6480464 |
CTD |
| G |
Gna14 |
guanine nucleotide binding protein, alpha 14 |
|
decreases expression |
ISO |
1 |
219,906,120 |
219,983,252 |
RGD:6480464 |
CTD |
| G |
Gna14 |
guanine nucleotide binding protein, alpha 14 |
|
multiple interactions |
ISO |
1 |
219,906,120 |
219,983,252 |
RGD:6480464 |
CTD |
| G |
Gnptg |
N-acetylglucosamine-1-phosphate transferase, gamma subunit |
|
multiple interactions |
ISO |
10 |
14,482,982 |
14,487,901 |
RGD:6480464 |
CTD |
| G |
Gnptg |
N-acetylglucosamine-1-phosphate transferase, gamma subunit |
|
decreases expression |
ISO |
10 |
14,482,982 |
14,487,901 |
RGD:6480464 |
CTD |
| G |
Gper |
G protein-coupled estrogen receptor 1 |
|
decreases expression |
EXP |
12 |
15,718,615 |
15,719,893 |
RGD:6480464 |
CTD |
| G |
Gpr1 |
G protein-coupled receptor 1 |
|
increases expression |
EXP |
9 |
61,837,807 |
61,838,868 |
RGD:6480464 |
CTD |
| G |
Gpr108 |
G protein-coupled receptor 108 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpr108 |
G protein-coupled receptor 108 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpr19 |
G protein-coupled receptor 19 |
|
decreases expression |
EXP |
4 |
171,791,727 |
171,809,215 |
RGD:6480464 |
CTD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
increases expression |
EXP |
3 |
46,832,380 |
46,952,670 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
decreases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grk5 |
G protein-coupled receptor kinase 5 |
|
decreases expression |
ISO |
1 |
267,495,534 |
267,693,144 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
affects expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
|
multiple interactions |
ISO |
1 |
99,563,187 |
99,577,802 |
RGD:6480464 |
CTD |
| G |
Hyou1 |
hypoxia up-regulated 1 |
|
decreases expression |
EXP |
8 |
47,346,753 |
47,358,869 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
decreases expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
multiple interactions |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
multiple interactions |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
decreases expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
multiple interactions |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
decreases expression |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
|
increases expression |
ISO |
17 |
72,557,196 |
72,563,149 |
RGD:6480464 |
CTD |
| G |
Ier2 |
immediate early response 2 |
|
multiple interactions |
ISO |
19 |
25,159,276 |
25,160,800 |
RGD:6480464 |
CTD |
| G |
Ier2 |
immediate early response 2 |
|
decreases expression |
ISO |
19 |
25,159,276 |
25,160,800 |
RGD:6480464 |
CTD |
| G |
Ifi27l2b |
interferon, alpha-inducible protein 27 like 2B |
|
multiple interactions |
ISO |
6 |
127,733,540 |
127,735,026 |
RGD:6480464 |
CTD |
| G |
Ifi27l2b |
interferon, alpha-inducible protein 27 like 2B |
|
increases expression |
ISO |
6 |
127,733,540 |
127,735,026 |
RGD:6480464 |
CTD |
| G |
Ifitm2 |
interferon induced transmembrane protein 2 |
|
increases expression |
ISO |
1 |
201,134,357 |
201,135,537 |
RGD:6480464 |
CTD |
| G |
Ifitm2 |
interferon induced transmembrane protein 2 |
|
multiple interactions |
ISO |
1 |
201,134,357 |
201,135,537 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
multiple interactions |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Ikbke |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
|
decreases expression |
ISO |
13 |
44,197,625 |
44,222,609 |
RGD:6480464 |
CTD |
| G |
Ikbke |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
|
multiple interactions |
ISO |
13 |
44,197,625 |
44,222,609 |
RGD:6480464 |
CTD |
| G |
Il1rap |
interleukin 1 receptor accessory protein |
|
decreases expression |
ISO |
11 |
76,092,252 |
76,222,576 |
RGD:6480464 |
CTD |
| G |
Il1rap |
interleukin 1 receptor accessory protein |
|
multiple interactions |
ISO |
11 |
76,092,252 |
76,222,576 |
RGD:6480464 |
CTD |
| G |
Impdh2 |
IMP (inosine 5'-monophosphate) dehydrogenase 2 |
|
decreases expression |
ISO |
8 |
113,607,025 |
113,611,613 |
RGD:6480464 |
CTD |
| G |
Impdh2 |
IMP (inosine 5'-monophosphate) dehydrogenase 2 |
|
multiple interactions |
ISO |
8 |
113,607,025 |
113,611,613 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
decreases expression |
ISO |
17 |
57,244,466 |
57,257,531 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
multiple interactions |
ISO |
17 |
57,244,466 |
57,257,531 |
RGD:6480464 |
CTD |
| G |
Inmt |
indolethylamine N-methyltransferase |
|
multiple interactions |
ISO |
4 |
83,934,018 |
83,938,314 |
RGD:6480464 |
CTD |
| G |
Inmt |
indolethylamine N-methyltransferase |
|
increases expression |
ISO |
4 |
83,934,018 |
83,938,314 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
decreases expression |
EXP |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
decreases expression |
ISO |
13 |
33,331,951 |
33,345,132 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
affects expression |
ISO |
13 |
33,331,951 |
33,345,132 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
multiple interactions |
ISO |
13 |
33,331,951 |
33,345,132 |
RGD:6480464 |
CTD |
| G |
Insl3 |
insulin-like 3 |
|
decreases expression |
EXP |
16 |
18,890,131 |
18,891,475 |
RGD:6480464 |
CTD |
| G |
Irf5 |
interferon regulatory factor 5 |
|
multiple interactions |
ISO |
4 |
56,407,560 |
56,418,694 |
RGD:6480464 |
CTD |
| G |
Irf5 |
interferon regulatory factor 5 |
|
decreases expression |
ISO |
4 |
56,407,560 |
56,418,694 |
RGD:6480464 |
CTD |
| G |
Irf6 |
interferon regulatory factor 6 |
|
multiple interactions |
ISO |
13 |
108,986,973 |
109,006,180 |
RGD:6480464 |
CTD |
| G |
Irf6 |
interferon regulatory factor 6 |
|
increases expression |
ISO |
13 |
108,986,973 |
109,006,180 |
RGD:6480464 |
CTD |
| G |
Isyna1 |
inositol-3-phosphate synthase 1 |
|
increases expression |
ISO |
16 |
19,345,305 |
19,348,141 |
RGD:6480464 |
CTD |
| G |
Isyna1 |
inositol-3-phosphate synthase 1 |
|
multiple interactions |
ISO |
16 |
19,345,305 |
19,348,141 |
RGD:6480464 |
CTD |
| G |
Jagn1 |
jagunal homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Lurap1l |
leucine rich adaptor protein 1-like |
|
decreases expression |
ISO |
5 |
99,599,574 |
99,647,041 |
RGD:6480464 |
CTD |
| G |
Lurap1l |
leucine rich adaptor protein 1-like |
|
multiple interactions |
ISO |
5 |
99,599,574 |
99,647,041 |
RGD:6480464 |
CTD |
| G |
Mppe1 |
metallophosphoesterase 1 |
|
multiple interactions |
ISO |
18 |
63,738,125 |
63,756,486 |
RGD:6480464 |
CTD |
| G |
Mrps18a |
mitochondrial ribosomal protein S18A |
|
multiple interactions |
ISO |
9 |
10,419,079 |
10,435,570 |
RGD:6480464 |
CTD |
| G |
Mrps18a |
mitochondrial ribosomal protein S18A |
|
increases expression |
ISO |
9 |
10,419,079 |
10,435,570 |
RGD:6480464 |
CTD |
| G |
Mrto4 |
mRNA turnover 4 homolog (S. cerevisiae) |
|
decreases expression |
EXP |
5 |
158,149,143 |
158,154,671 |
RGD:6480464 |
CTD |
| G |
Msmo1 |
methylsterol monooxygenase 1 |
|
increases expression |
ISO |
16 |
26,698,324 |
26,716,247 |
RGD:6480464 |
CTD |
| G |
Msmo1 |
methylsterol monooxygenase 1 |
|
multiple interactions |
ISO |
16 |
26,698,324 |
26,716,247 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
decreases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
affects expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
decreases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mvd |
mevalonate (diphospho) decarboxylase |
|
increases expression |
ISO |
19 |
52,722,306 |
52,732,312 |
RGD:6480464 |
CTD |
| G |
Mvp |
major vault protein |
|
multiple interactions |
ISO |
1 |
186,164,811 |
186,192,802 |
RGD:6480464 |
CTD |
| G |
Mvp |
major vault protein |
|
increases expression |
ISO |
1 |
186,164,811 |
186,192,802 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
multiple interactions |
ISO |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
decreases expression |
ISO |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
| G |
Nab2 |
Ngfi-A binding protein 2 |
|
multiple interactions |
ISO |
7 |
67,642,321 |
67,648,713 |
RGD:6480464 |
CTD |
| G |
Nab2 |
Ngfi-A binding protein 2 |
|
decreases expression |
ISO |
7 |
67,642,321 |
67,648,713 |
RGD:6480464 |
CTD |
| G |
Nae1 |
NEDD8 activating enzyme E1 subunit 1 |
|
multiple interactions |
ISO |
19 |
382,556 |
408,667 |
RGD:6480464 |
CTD |
| G |
Nae1 |
NEDD8 activating enzyme E1 subunit 1 |
|
decreases expression |
ISO |
19 |
382,556 |
408,667 |
RGD:6480464 |
CTD |
| G |
Nat8 |
N-acetyltransferase 8 |
|
decreases expression |
ISO |
4 |
120,001,277 |
120,002,055 |
RGD:6480464 |
CTD |
| G |
Nat8 |
N-acetyltransferase 8 |
|
multiple interactions |
ISO |
4 |
120,001,277 |
120,002,055 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
6 |
27,224,396 |
27,473,926 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated 1 |
|
increases expression |
ISO |
7 |
104,302,038 |
104,344,842 |
RGD:6480464 |
CTD |
| G |
Ndufa13 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 |
|
decreases expression |
ISO |
7 |
32,937,677 |
32,938,111 |
RGD:6480464 |
CTD |
| G |
Ndufa13 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 |
|
multiple interactions |
ISO |
7 |
32,937,677 |
32,938,111 |
RGD:6480464 |
CTD |
| G |
Ndufa3 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 |
|
increases expression |
ISO |
1 |
63,910,487 |
63,913,120 |
RGD:6480464 |
CTD |
| G |
Ndufa3 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 |
|
multiple interactions |
ISO |
1 |
63,910,487 |
63,913,120 |
RGD:6480464 |
CTD |
| G |
Ndufaf2 |
NADH dehydrogenase (ubiquinone) complex I, assembly factor 2 |
|
increases expression |
ISO |
2 |
39,269,415 |
39,382,833 |
RGD:6480464 |
CTD |
| G |
Ndufaf2 |
NADH dehydrogenase (ubiquinone) complex I, assembly factor 2 |
|
multiple interactions |
ISO |
2 |
39,269,415 |
39,382,833 |
RGD:6480464 |
CTD |
| G |
Ndufb2 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 |
|
multiple interactions |
ISO |
4 |
67,099,841 |
67,106,920 |
RGD:6480464 |
CTD |
| G |
Ndufb2 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 |
|
decreases expression |
ISO |
4 |
67,099,841 |
67,106,920 |
RGD:6480464 |
CTD |
| G |
Necab1 |
N-terminal EF-hand calcium binding protein 1 |
|
decreases expression |
ISO |
5 |
29,427,273 |
29,664,037 |
RGD:6480464 |
CTD |
| G |
Necab1 |
N-terminal EF-hand calcium binding protein 1 |
|
multiple interactions |
ISO |
5 |
29,427,273 |
29,664,037 |
RGD:6480464 |
CTD |
| G |
Nfia |
nuclear factor I/A |
|
multiple interactions |
ISO |
5 |
118,152,938 |
118,507,056 |
RGD:6480464 |
CTD |
| G |
Nfia |
nuclear factor I/A |
|
decreases expression |
ISO |
5 |
118,152,938 |
118,507,056 |
RGD:6480464 |
CTD |
| G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
|
increases expression |
EXP |
17 |
18,092,489 |
18,107,708 |
RGD:6480464 |
CTD |
| G |
Nipsnap3a |
nipsnap homolog 3A (C. elegans) |
|
increases expression |
ISO |
5 |
70,425,039 |
70,435,740 |
RGD:6480464 |
CTD |
| G |
Nipsnap3a |
nipsnap homolog 3A (C. elegans) |
|
multiple interactions |
ISO |
5 |
70,425,039 |
70,435,740 |
RGD:6480464 |
CTD |
| G |
Nln |
neurolysin (metallopeptidase M3 family) |
|
increases expression |
ISO |
2 |
34,915,111 |
35,031,566 |
RGD:6480464 |
CTD |
| G |
Nln |
neurolysin (metallopeptidase M3 family) |
|
multiple interactions |
ISO |
2 |
34,915,111 |
35,031,566 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
|
decreases expression |
EXP |
X |
73,006,294 |
73,010,422 |
RGD:6480464 |
CTD |
| G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
|
increases expression |
ISO |
5 |
49,544,328 |
49,547,367 |
RGD:6480464 |
CTD |
| G |
Pole4 |
polymerase (DNA-directed), epsilon 4, accessory subunit |
|
multiple interactions |
ISO |
4 |
116,856,445 |
116,862,256 |
RGD:6480464 |
CTD |
| G |
Pomp |
proteasome maturation protein |
|
increases expression |
ISO |
12 |
7,719,721 |
7,732,544 |
RGD:6480464 |
CTD |
| G |
Pomp |
proteasome maturation protein |
|
multiple interactions |
ISO |
12 |
7,719,721 |
7,732,544 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
multiple interactions |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Pou2f1 |
POU class 2 homeobox 1 |
|
decreases expression |
ISO |
13 |
81,607,326 |
81,739,958 |
RGD:6480464 |
CTD |
| G |
Pou2f1 |
POU class 2 homeobox 1 |
|
multiple interactions |
ISO |
13 |
81,607,326 |
81,739,958 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases activity |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
decreases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases activity |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
increases expression |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
affects expression |
EXP |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppl |
periplakin |
|
multiple interactions |
ISO |
10 |
10,566,823 |
10,612,474 |
RGD:6480464 |
CTD |
| G |
Ppl |
periplakin |
|
increases expression |
ISO |
10 |
10,566,823 |
10,612,474 |
RGD:6480464 |
CTD |
| G |
Ppp2r5c |
protein phosphatase 2, regulatory subunit B', gamma |
|
increases expression |
ISO |
6 |
135,204,405 |
135,299,068 |
RGD:6480464 |
CTD |
| G |
Ppp2r5c |
protein phosphatase 2, regulatory subunit B', gamma |
|
multiple interactions |
ISO |
6 |
135,204,405 |
135,299,068 |
RGD:6480464 |
CTD |
| G |
Prdx4 |
peroxiredoxin 4 |
|
decreases expression |
EXP |
X |
61,501,206 |
61,516,286 |
RGD:6480464 |
CTD |
| G |
Prlr |
prolactin receptor |
|
multiple interactions |
ISO |
2 |
59,507,966 |
59,701,221 |
RGD:6480464 |
CTD |
| G |
Prlr |
prolactin receptor |
|
increases expression |
ISO |
2 |
59,507,966 |
59,701,221 |
RGD:6480464 |
CTD |
| G |
Prodh |
proline dehydrogenase (oxidase) 1 |
|
decreases expression |
ISO |
11 |
84,905,060 |
84,922,229 |
RGD:6480464 |
CTD |
| G |
Prodh |
proline dehydrogenase (oxidase) 1 |
|
multiple interactions |
ISO |
11 |
84,905,060 |
84,922,229 |
RGD:6480464 |
CTD |
| G |
Psma2 |
proteasome (prosome, macropain) subunit, alpha type 2 |
|
multiple interactions |
ISO |
17 |
58,736,300 |
58,746,837 |
RGD:6480464 |
CTD |
| G |
Psma2 |
proteasome (prosome, macropain) subunit, alpha type 2 |
|
decreases expression |
ISO |
17 |
58,736,300 |
58,746,837 |
RGD:6480464 |
CTD |
| G |
Psma6 |
proteasome (prosome, macropain) subunit, alpha type 6 |
|
decreases expression |
EXP |
6 |
75,649,844 |
75,667,404 |
RGD:6480464 |
CTD |
| G |
Psmd14 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
|
increases expression |
ISO |
3 |
43,660,136 |
43,699,412 |
RGD:6480464 |
CTD |
| G |
Psmd14 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
|
multiple interactions |
ISO |
3 |
43,660,136 |
43,699,412 |
RGD:6480464 |
CTD |
| G |
Psme1 |
proteasome (prosome, macropain) activator subunit 1 |
|
increases expression |
ISO |
15 |
33,712,892 |
33,715,769 |
RGD:6480464 |
CTD |
| G |
Psme1 |
proteasome (prosome, macropain) activator subunit 1 |
|
multiple interactions |
ISO |
15 |
33,712,892 |
33,715,769 |
RGD:6480464 |
CTD |
| G |
Psme1 |
proteasome (prosome, macropain) activator subunit 1 |
|
decreases expression |
EXP |
15 |
33,712,892 |
33,715,769 |
RGD:6480464 |
CTD |
| G |
RGD1562136 |
similar to D1Ertd622e protein |
|
decreases expression |
ISO |
9 |
97,216,277 |
97,236,238 |
RGD:6480464 |
CTD |
| G |
RGD1562136 |
similar to D1Ertd622e protein |
|
multiple interactions |
ISO |
9 |
97,216,277 |
97,236,238 |
RGD:6480464 |
CTD |
| G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
increases expression |
ISO |
2 |
211,851,304 |
211,855,511 |
RGD:6480464 |
CTD |
| G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
multiple interactions |
ISO |
2 |
211,851,304 |
211,855,511 |
RGD:6480464 |
CTD |
| G |
Sc5d |
sterol-C5-desaturase |
|
increases expression |
ISO |
8 |
45,229,976 |
45,238,924 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
decreases expression |
EXP |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scn2a1 |
sodium channel, voltage-gated, type II, alpha 1 |
|
multiple interactions |
ISO |
3 |
47,588,413 |
47,722,800 |
RGD:6480464 |
CTD |
| G |
Scn2a1 |
sodium channel, voltage-gated, type II, alpha 1 |
|
decreases expression |
ISO |
3 |
47,588,413 |
47,722,800 |
RGD:6480464 |
CTD |
| G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
|
decreases expression |
ISO |
4 |
161,445,936 |
161,469,267 |
RGD:6480464 |
CTD |
| G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
|
multiple interactions |
ISO |
4 |
161,445,936 |
161,469,267 |
RGD:6480464 |
CTD |
| G |
Scpep1 |
serine carboxypeptidase 1 |
|
increases expression |
ISO |
10 |
77,347,473 |
77,377,945 |
RGD:6480464 |
CTD |
| G |
Scpep1 |
serine carboxypeptidase 1 |
|
multiple interactions |
ISO |
10 |
77,347,473 |
77,377,945 |
RGD:6480464 |
CTD |
| G |
Sdc2 |
syndecan 2 |
|
decreases expression |
ISO |
7 |
68,290,558 |
68,405,183 |
RGD:6480464 |
CTD |
| G |
Sdc2 |
syndecan 2 |
|
multiple interactions |
ISO |
7 |
68,290,558 |
68,405,183 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
increases expression |
ISO |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
multiple interactions |
ISO |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Sec14l2 |
SEC14-like 2 (S. cerevisiae) |
|
increases expression |
ISO |
14 |
84,728,484 |
84,748,418 |
RGD:6480464 |
CTD |
| G |
Sec14l2 |
SEC14-like 2 (S. cerevisiae) |
|
multiple interactions |
ISO |
14 |
84,728,484 |
84,748,418 |
RGD:6480464 |
CTD |
| G |
Sec61g |
SEC61, gamma subunit |
|
decreases expression |
ISO |
14 |
97,323,315 |
97,329,689 |
RGD:6480464 |
CTD |
| G |
Sec61g |
SEC61, gamma subunit |
|
multiple interactions |
ISO |
14 |
97,323,315 |
97,329,689 |
RGD:6480464 |
CTD |
| G |
Sel1l3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
|
increases expression |
ISO |
14 |
62,523,392 |
62,630,921 |
RGD:6480464 |
CTD |
| G |
Sel1l3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
|
multiple interactions |
ISO |
14 |
62,523,392 |
62,630,921 |
RGD:6480464 |
CTD |
| G |
Selplg |
selectin P ligand |
|
increases expression |
ISO |
12 |
43,842,268 |
43,843,560 |
RGD:6480464 |
CTD |
| G |
Selplg |
selectin P ligand |
|
multiple interactions |
ISO |
12 |
43,842,268 |
43,843,560 |
RGD:6480464 |
CTD |
| G |
Serinc2 |
serine incorporator 2 |
|
increases expression |
ISO |
5 |
149,279,136 |
149,301,805 |
RGD:6480464 |
CTD |
| G |
Serinc2 |
serine incorporator 2 |
|
multiple interactions |
ISO |
5 |
149,279,136 |
149,301,805 |
RGD:6480464 |
CTD |
| G |
Serp1 |
stress-associated endoplasmic reticulum protein 1 |
|
decreases expression |
ISO |
2 |
147,866,072 |
147,870,096 |
RGD:6480464 |
CTD |
| G |
Serp1 |
stress-associated endoplasmic reticulum protein 1 |
|
multiple interactions |
ISO |
2 |
147,866,072 |
147,870,096 |
RGD:6480464 |
CTD |
| G |
Serpina12 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
|
decreases expression |
ISO |
6 |
128,086,068 |
128,100,843 |
RGD:6480464 |
CTD |
| G |
Serpina12 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
|
multiple interactions |
ISO |
6 |
128,086,068 |
128,100,843 |
RGD:6480464 |
CTD |
| G |
Spry4 |
sprouty homolog 4 (Drosophila) |
|
decreases expression |
ISO |
18 |
31,532,680 |
31,547,586 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Steap4 |
STEAP family member 4 |
|
affects expression |
ISO |
4 |
22,688,597 |
22,711,432 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
decreases expression |
ISO |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
multiple interactions |
ISO |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1d1 |
sulfotransferase family 1D, member 1 |
|
decreases expression |
ISO |
14 |
21,983,705 |
22,002,744 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
decreases expression |
ISO |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
multiple interactions |
ISO |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Sumo1 |
SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) |
|
multiple interactions |
ISO |
9 |
58,212,538 |
58,242,760 |
RGD:6480464 |
CTD |
| G |
Sumo1 |
SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) |
|
increases expression |
ISO |
9 |
58,212,538 |
58,242,760 |
RGD:6480464 |
CTD |
| G |
Suox |
sulfite oxidase |
|
decreases expression |
ISO |
7 |
1,973,471 |
1,976,040 |
RGD:6480464 |
CTD |
| G |
Suox |
sulfite oxidase |
|
multiple interactions |
ISO |
7 |
1,973,471 |
1,976,040 |
RGD:6480464 |
CTD |
| G |
Suox |
sulfite oxidase |
|
increases expression |
ISO |
7 |
1,973,471 |
1,976,040 |
RGD:6480464 |
CTD |
| G |
Svs5 |
seminal vesicle secretory protein 5 |
|
decreases expression |
EXP |
3 |
155,265,150 |
155,266,754 |
RGD:6480464 |
CTD |
| G |
Tacr1 |
tachykinin receptor 1 |
|
increases expression |
EXP |
4 |
116,610,595 |
116,780,394 |
RGD:6480464 |
CTD |
| G |
Tacr2 |
tachykinin receptor 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Taf13 |
TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
decreases expression |
ISO |
2 |
204,136,548 |
204,147,904 |
RGD:6480464 |
CTD |
| G |
Taf13 |
TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
multiple interactions |
ISO |
2 |
204,136,548 |
204,147,904 |
RGD:6480464 |
CTD |
| G |
Tceal8 |
transcription elongation factor A (SII)-like 8 |
|
decreases expression |
ISO |
X |
123,481,666 |
123,482,635 |
RGD:6480464 |
CTD |
| G |
Tceal8 |
transcription elongation factor A (SII)-like 8 |
|
multiple interactions |
ISO |
X |
123,481,666 |
123,482,635 |
RGD:6480464 |
CTD |
| G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
|
multiple interactions |
ISO |
4 |
28,807,080 |
28,811,502 |
RGD:6480464 |
CTD |
| G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
|
increases expression |
ISO |
4 |
28,807,080 |
28,811,502 |
RGD:6480464 |
CTD |
| G |
Thnsl2 |
threonine synthase-like 2 (S. cerevisiae) |
|
increases expression |
ISO |
4 |
104,329,517 |
104,348,465 |
RGD:6480464 |
CTD |
| G |
Thnsl2 |
threonine synthase-like 2 (S. cerevisiae) |
|
multiple interactions |
ISO |
4 |
104,329,517 |
104,348,465 |
RGD:6480464 |
CTD |
| G |
Timm10 |
translocase of inner mitochondrial membrane 10 homolog (yeast) |
|
decreases expression |
ISO |
3 |
68,036,888 |
68,040,362 |
RGD:6480464 |
CTD |
| G |
Timm10 |
translocase of inner mitochondrial membrane 10 homolog (yeast) |
|
multiple interactions |
ISO |
3 |
68,036,888 |
68,040,362 |
RGD:6480464 |
CTD |
| G |
Timm13 |
translocase of inner mitochondrial membrane 13 homolog (yeast) |
|
decreases expression |
ISO |
7 |
10,319,959 |
10,321,062 |
RGD:6480464 |
CTD |
| G |
Timm13 |
translocase of inner mitochondrial membrane 13 homolog (yeast) |
|
multiple interactions |
ISO |
7 |
10,319,959 |
10,321,062 |
RGD:6480464 |
CTD |
| G |
Timm9 |
translocase of inner mitochondrial membrane 9 homolog (yeast) |
|
decreases expression |
ISO |
6 |
93,218,517 |
93,231,326 |
RGD:6480464 |
CTD |
| G |
Timm9 |
translocase of inner mitochondrial membrane 9 homolog (yeast) |
|
multiple interactions |
ISO |
6 |
93,218,517 |
93,231,326 |
RGD:6480464 |
CTD |
| G |
Tm4sf4 |
transmembrane 4 L six family member 4 |
|
decreases expression |
ISO |
2 |
146,668,853 |
146,684,081 |
RGD:6480464 |
CTD |
| G |
Tm4sf4 |
transmembrane 4 L six family member 4 |
|
multiple interactions |
ISO |
2 |
146,668,853 |
146,684,081 |
RGD:6480464 |
CTD |
| G |
Tmem141 |
transmembrane protein 141 |
|
decreases expression |
ISO |
3 |
3,791,545 |
3,793,503 |
RGD:6480464 |
CTD |
| G |
Tmem141 |
transmembrane protein 141 |
|
multiple interactions |
ISO |
3 |
3,791,545 |
3,793,503 |
RGD:6480464 |
CTD |
| G |
Tmem184a |
transmembrane protein 184A |
|
multiple interactions |
ISO |
12 |
15,301,547 |
15,309,858 |
RGD:6480464 |
CTD |
| G |
Tmem37 |
transmembrane protein 37 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
mono(2-ethylhexyl) phthalate
|
| G |
Abca12 |
ATP-binding cassette, subfamily A (ABC1), member 12 |
|
increases expression |
ISO |
9 |
70,328,327 |
70,501,128 |
RGD:6480464 |
CTD |
| G |
Abca4 |
ATP-binding cassette, subfamily A (ABC1), member 4 |
|
increases expression |
ISO |
2 |
218,712,663 |
218,849,896 |
RGD:6480464 |
CTD |
| G |
Abca7 |
ATP-binding cassette, subfamily A (ABC1), member 7 |
|
decreases expression |
ISO |
7 |
11,203,983 |
11,222,960 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
decreases expression |
ISO |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcb9 |
ATP-binding cassette, subfamily B (MDR/TAP), member 9 |
|
increases expression |
ISO |
12 |
33,623,383 |
33,656,242 |
RGD:6480464 |
CTD |
| G |
Abcc10 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 10 |
|
decreases expression |
ISO |
9 |
10,219,822 |
10,239,734 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
increases expression |
ISO |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Acads |
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
|
increases expression |
EXP |
12 |
42,765,284 |
42,774,528 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acoxl |
acyl-CoA oxidase-like |
|
decreases expression |
ISO |
3 |
115,365,279 |
115,687,566 |
RGD:6480464 |
CTD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
decreases expression |
ISO |
X |
36,168,547 |
36,232,162 |
RGD:6480464 |
CTD |
| G |
Adam22 |
ADAM metallopeptidase domain 22 |
|
decreases expression |
ISO |
4 |
22,332,086 |
22,507,086 |
RGD:6480464 |
CTD |
| G |
Adam23 |
ADAM metallopeptidase domain 23 |
|
decreases expression |
ISO |
9 |
62,106,282 |
62,250,036 |
RGD:6480464 |
CTD |
| G |
Adamts4 |
ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
|
decreases expression |
ISO |
13 |
87,142,442 |
87,151,783 |
RGD:6480464 |
CTD |
| G |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
|
decreases expression |
ISO |
17 |
72,680,982 |
73,238,156 |
RGD:6480464 |
CTD |
| G |
Adcy4 |
adenylate cyclase 4 |
|
decreases expression |
ISO |
15 |
33,930,531 |
33,946,352 |
RGD:6480464 |
CTD |
| G |
Adcy7 |
adenylate cyclase 7 |
|
decreases expression |
ISO |
19 |
20,051,639 |
20,073,861 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
decreases expression |
ISO |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
decreases expression |
ISO |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Afm |
afamin |
|
increases expression |
ISO |
14 |
19,049,664 |
19,082,977 |
RGD:6480464 |
CTD |
| G |
Agbl3 |
ATP/GTP binding protein-like 3 |
|
increases expression |
ISO |
4 |
62,167,594 |
62,256,297 |
RGD:6480464 |
CTD |
| G |
Agl |
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
|
multiple interactions |
EXP |
2 |
212,985,676 |
213,041,451 |
RGD:6480464 |
CTD |
| G |
Agtr1b |
angiotensin II receptor, type 1b |
|
decreases expression |
ISO |
2 |
105,503,269 |
105,602,591 |
RGD:6480464 |
CTD |
| G |
Ahcy |
adenosylhomocysteinase |
|
decreases expression |
ISO |
3 |
145,544,834 |
145,560,058 |
RGD:6480464 |
CTD |
| G |
Aifm3 |
apoptosis-inducing factor, mitochondrion-associated 3 |
|
increases expression |
ISO |
11 |
85,496,302 |
85,512,831 |
RGD:6480464 |
CTD |
| G |
Ajuba |
ajuba LIM protein |
|
increases expression |
EXP |
15 |
32,627,633 |
32,637,861 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
affects response to substance |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases activity |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1s1 |
AKT1 substrate 1 (proline-rich) |
|
decreases expression |
ISO |
1 |
95,325,272 |
95,328,510 |
RGD:6480464 |
CTD |
| G |
Amh |
anti-Mullerian hormone |
|
decreases expression |
ISO |
7 |
10,417,325 |
10,419,673 |
RGD:6480464 |
CTD |
| G |
Amh |
anti-Mullerian hormone |
|
decreases expression |
EXP |
7 |
10,417,325 |
10,419,673 |
RGD:6480464 |
CTD |
| G |
Ank1 |
ankyrin 1, erythrocytic |
|
increases expression |
ISO |
16 |
73,333,564 |
73,437,926 |
RGD:6480464 |
CTD |
| G |
Ano9 |
anoctamin 9 |
|
increases expression |
ISO |
1 |
201,298,523 |
201,323,708 |
RGD:6480464 |
CTD |
| G |
Antxr2 |
anthrax toxin receptor 2 |
|
decreases expression |
ISO |
14 |
12,875,632 |
13,107,975 |
RGD:6480464 |
CTD |
| G |
Antxr2 |
anthrax toxin receptor 2 |
|
decreases expression |
ISO |
14 |
12,875,632 |
13,107,975 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
increases expression |
ISO |
9 |
56,693,698 |
56,774,115 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
increases expression |
EXP |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Artn |
artemin |
|
increases expression |
ISO |
5 |
138,390,981 |
138,394,250 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf7ip2 |
activating transcription factor 7 interacting protein 2 |
|
increases expression |
ISO |
10 |
5,356,438 |
5,399,673 |
RGD:6480464 |
CTD |
| G |
Atp12a |
ATPase, H+/K+ transporting, nongastric, alpha polypeptide |
|
decreases expression |
ISO |
15 |
35,295,274 |
35,321,453 |
RGD:6480464 |
CTD |
| G |
Atp13a4 |
ATPase type 13A4 |
|
increases expression |
ISO |
11 |
73,163,802 |
73,251,192 |
RGD:6480464 |
CTD |
| G |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
|
decreases expression |
ISO |
1 |
80,280,714 |
80,309,834 |
RGD:6480464 |
CTD |
| G |
Atp6v1c2 |
ATPase, H+ transporting, lysosomal V1 subunit C2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp6v1h |
ATPase, H+ transporting, lysosomal V1 subunit H |
|
affects expression |
ISO |
5 |
14,578,149 |
14,683,476 |
RGD:6480464 |
CTD |
| G |
Atp8b4 |
ATPase, class I, type 8B, member 4 |
|
decreases expression |
ISO |
3 |
113,781,099 |
113,943,532 |
RGD:6480464 |
CTD |
| G |
Atp9b |
ATPase, class II, type 9B |
|
increases expression |
ISO |
18 |
77,616,788 |
77,812,509 |
RGD:6480464 |
CTD |
| G |
Atrnl1 |
attractin like 1 |
|
increases expression |
ISO |
1 |
263,919,358 |
264,486,579 |
RGD:6480464 |
CTD |
| G |
Avpi1 |
arginine vasopressin-induced 1 |
|
decreases expression |
ISO |
1 |
248,727,385 |
248,733,112 |
RGD:6480464 |
CTD |
| G |
B3galt1 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
|
increases expression |
EXP |
3 |
50,146,767 |
50,160,110 |
RGD:6480464 |
CTD |
| G |
B3galt2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
|
decreases expression |
ISO |
13 |
57,474,131 |
57,483,142 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Baz1a |
bromodomain adjacent to zinc finger domain, 1A |
|
decreases expression |
ISO |
6 |
75,239,089 |
75,327,488 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
increases expression |
EXP |
11 |
79,006,123 |
79,030,555 |
RGD:6480464 |
CTD |
| G |
Bean1 |
brain expressed, associated with NEDD4, 1 |
|
decreases expression |
ISO |
19 |
698,197 |
744,853 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
decreases expression |
ISO |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
Bpifb6 |
BPI fold containing family B, member 6 |
|
decreases expression |
ISO |
3 |
144,293,297 |
144,297,498 |
RGD:6480464 |
CTD |
| G |
Brd3 |
bromodomain containing 3 |
|
increases expression |
ISO |
3 |
6,369,903 |
6,390,116 |
RGD:6480464 |
CTD |
| G |
Brsk1 |
BR serine/threonine kinase 1 |
|
decreases expression |
ISO |
1 |
67,851,020 |
67,876,360 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
EXP |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Bves |
blood vessel epicardial substance |
|
decreases expression |
ISO |
20 |
49,671,174 |
49,671,683 |
RGD:6480464 |
CTD |
| G |
C1qtnf6 |
C1q and tumor necrosis factor related protein 6 |
|
decreases expression |
ISO |
7 |
116,479,791 |
116,486,309 |
RGD:6480464 |
CTD |
| G |
C8a |
complement component 8, alpha polypeptide |
|
increases expression |
ISO |
5 |
125,776,549 |
125,831,049 |
RGD:6480464 |
CTD |
| G |
Cabp1 |
calcium binding protein 1 |
|
decreases expression |
ISO |
12 |
42,696,383 |
42,720,566 |
RGD:6480464 |
CTD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
affects expression |
ISO |
8 |
50,765,645 |
51,108,962 |
RGD:6480464 |
CTD |
| G |
Camk1d |
calcium/calmodulin-dependent protein kinase ID |
|
increases expression |
ISO |
17 |
83,649,720 |
84,061,160 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbs |
cystathionine beta synthase |
|
affects expression |
ISO |
20 |
10,047,478 |
10,075,520 |
RGD:6480464 |
CTD |
| G |
Ccdc27 |
coiled-coil domain containing 27 |
|
increases expression |
ISO |
5 |
170,813,187 |
170,827,158 |
RGD:6480464 |
CTD |
| G |
Ccdc96 |
coiled-coil domain containing 96 |
|
affects expression |
ISO |
14 |
79,857,379 |
79,859,699 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
affects expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
decreases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
multiple interactions |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccno |
cyclin O |
|
affects expression |
ISO |
2 |
44,377,953 |
44,381,020 |
RGD:6480464 |
CTD |
| G |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
|
increases expression |
EXP |
8 |
115,451,786 |
115,454,088 |
RGD:6480464 |
CTD |
| G |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
|
decreases expression |
ISO |
8 |
115,451,786 |
115,454,088 |
RGD:6480464 |
CTD |
| G |
Cd109 |
CD109 molecule |
|
affects expression |
ISO |
8 |
83,576,559 |
83,672,664 |
RGD:6480464 |
CTD |
| G |
Cd109 |
CD109 molecule |
|
decreases expression |
ISO |
8 |
83,576,559 |
83,672,664 |
RGD:6480464 |
CTD |
| G |
Cd163 |
CD163 molecule |
|
increases expression |
ISO |
4 |
160,394,833 |
160,428,208 |
RGD:6480464 |
CTD |
| G |
Cd24 |
CD24 molecule |
|
affects expression |
ISO |
20 |
47,502,354 |
47,507,663 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
affects expression |
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd69 |
Cd69 molecule |
|
increases expression |
EXP |
4 |
166,527,683 |
166,535,601 |
RGD:6480464 |
CTD |
| G |
Cdh23 |
cadherin-related 23 |
|
increases expression |
ISO |
20 |
27,622,049 |
28,016,145 |
RGD:6480464 |
CTD |
| G |
Cdhr2 |
cadherin-related family member 2 |
|
decreases expression |
ISO |
17 |
15,937,987 |
15,962,796 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases activity |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
increases expression |
EXP |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
EXP |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
EXP |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
|
multiple interactions |
ISO |
2 |
203,960,513 |
203,983,133 |
RGD:6480464 |
CTD |
| G |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
|
affects transport |
ISO |
2 |
203,960,513 |
203,983,133 |
RGD:6480464 |
CTD |
| G |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
|
increases phosphorylation |
ISO |
2 |
203,960,513 |
203,983,133 |
RGD:6480464 |
CTD |
| G |
Ces1e |
carboxylesterase 1E |
|
increases expression |
ISO |
19 |
14,887,900 |
14,924,363 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
multiple interactions |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
multiple interactions |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
increases expression |
EXP |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chd5 |
chromodomain helicase DNA binding protein 5 |
|
increases expression |
ISO |
5 |
169,570,804 |
169,616,812 |
RGD:6480464 |
CTD |
| G |
Chrd |
chordin |
|
affects expression |
ISO |
11 |
82,401,701 |
82,410,401 |
RGD:6480464 |
CTD |
| G |
Chrna9 |
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
|
affects expression |
ISO |
14 |
44,906,566 |
44,913,821 |
RGD:6480464 |
CTD |
| G |
Clasp2 |
cytoplasmic linker associated protein 2 |
|
decreases expression |
ISO |
8 |
118,454,426 |
118,562,702 |
RGD:6480464 |
CTD |
| G |
Cldn18 |
claudin 18 |
|
decreases expression |
ISO |
8 |
104,560,892 |
104,578,313 |
RGD:6480464 |
CTD |
| G |
Clstn3 |
calsyntenin 3 |
|
decreases expression |
ISO |
4 |
160,631,047 |
160,665,193 |
RGD:6480464 |
CTD |
| G |
Cnga2 |
cyclic nucleotide gated channel alpha 2 |
|
increases expression |
ISO |
X |
157,558,962 |
157,575,781 |
RGD:6480464 |
CTD |
| G |
Cnga4 |
cyclic nucleotide gated channel alpha 4 |
|
increases expression |
ISO |
1 |
163,137,544 |
163,141,556 |
RGD:6480464 |
CTD |
| G |
Cntn3 |
contactin 3 (plasmacytoma associated) |
|
decreases expression |
ISO |
4 |
137,121,006 |
137,421,081 |
RGD:6480464 |
CTD |
| G |
Cntnap5a |
contactin associated protein-like 5A |
|
decreases expression |
ISO |
13 |
28,709,670 |
29,730,378 |
RGD:6480464 |
CTD |
| G |
Cntrl |
centriolin |
|
increases expression |
ISO |
3 |
14,168,983 |
14,242,139 |
RGD:6480464 |
CTD |
| G |
Col12a1 |
collagen, type XII, alpha 1 |
|
decreases expression |
ISO |
8 |
84,641,358 |
84,756,923 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
increases expression |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Cpa5 |
carboxypeptidase A5 |
|
decreases expression |
ISO |
4 |
57,522,649 |
57,541,340 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
decreases expression |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Crhbp |
corticotropin releasing hormone binding protein |
|
decreases expression |
ISO |
2 |
25,801,371 |
25,813,457 |
RGD:6480464 |
CTD |
| G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
increases expression |
ISO |
4 |
83,839,822 |
83,867,017 |
RGD:6480464 |
CTD |
| G |
Csnk1a1 |
casein kinase 1, alpha 1 |
|
multiple interactions |
ISO |
18 |
57,541,673 |
57,564,560 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Cth |
cystathionase (cystathionine gamma-lyase) |
|
affects expression |
ISO |
2 |
256,056,562 |
256,082,248 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cubn |
cubilin (intrinsic factor-cobalamin receptor) |
|
decreases expression |
ISO |
17 |
87,545,893 |
87,772,079 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
EXP |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
increases metabolic processing |
EXP |
1 |
243,859,015 |
243,896,003 |
RGD:6480464 |
CTD |
| G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
multiple interactions |
EXP |
1 |
243,859,015 |
243,896,003 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases metabolic processing |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases metabolic processing |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
decreases expression |
EXP |
4 |
26,752,677 |
26,771,131 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
increases expression |
EXP |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Derl3 |
derlin 3 |
|
affects expression |
ISO |
20 |
13,163,287 |
13,165,848 |
RGD:6480464 |
CTD |
| G |
Dgkb |
diacylglycerol kinase, beta |
|
decreases expression |
ISO |
6 |
56,715,327 |
57,479,656 |
RGD:6480464 |
CTD |
| G |
Dhcr24 |
24-dehydrocholesterol reductase |
|
decreases expression |
ISO |
5 |
127,637,438 |
127,662,621 |
RGD:6480464 |
CTD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
affects expression |
EXP |
1 |
204,245,562 |
204,258,913 |
RGD:6480464 |
CTD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
decreases expression |
EXP |
1 |
204,245,562 |
204,258,913 |
RGD:6480464 |
CTD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
affects expression |
EXP |
1 |
204,245,562 |
204,258,913 |
RGD:6480464 |
CTD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
decreases expression |
ISO |
1 |
204,245,562 |
204,258,913 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
decreases expression |
ISO |
12 |
34,196,347 |
34,209,633 |
RGD:6480464 |
CTD |
| G |
Dmd |
dystrophin |
|
increases expression |
ISO |
X |
71,501,362 |
71,671,414 |
RGD:6480464 |
CTD |
| G |
Dnah8 |
dynein, axonemal, heavy chain 8 |
|
increases expression |
ISO |
20 |
8,936,173 |
9,199,913 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
increases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dpep1 |
dipeptidase 1 (renal) |
|
decreases expression |
ISO |
19 |
53,503,467 |
53,518,440 |
RGD:6480464 |
CTD |
| G |
Dpep2 |
dipeptidase 2 |
|
decreases expression |
ISO |
19 |
35,832,224 |
35,838,659 |
RGD:6480464 |
CTD |
| G |
Dpp6 |
dipeptidylpeptidase 6 |
|
increases expression |
ISO |
4 |
2,853,479 |
3,565,666 |
RGD:6480464 |
CTD |
| G |
Dpy19l1 |
dpy-19-like 1 (C. elegans) |
|
decreases expression |
ISO |
8 |
24,072,769 |
24,160,500 |
RGD:6480464 |
CTD |
| G |
Dpysl4 |
dihydropyrimidinase-like 4 |
|
decreases expression |
ISO |
1 |
198,866,034 |
198,881,902 |
RGD:6480464 |
CTD |
| G |
Dsc2 |
desmocollin 2 |
|
decreases expression |
ISO |
18 |
11,902,185 |
11,933,989 |
RGD:6480464 |
CTD |
| G |
Dst |
dystonin |
|
increases expression |
ISO |
9 |
32,757,554 |
33,051,275 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
decreases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
increases expression |
EXP |
1 |
259,754,234 |
259,767,645 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
increases expression |
EXP |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Ebf3 |
early B-cell factor 3 |
|
decreases expression |
ISO |
1 |
196,927,457 |
197,045,432 |
RGD:6480464 |
CTD |
| G |
Ebp |
emopamil binding protein (sterol isomerase) |
|
increases expression |
EXP |
X |
26,331,199 |
26,337,542 |
RGD:6480464 |
CTD |
| G |
Ecm1 |
extracellular matrix protein 1 |
|
decreases expression |
ISO |
2 |
190,525,156 |
190,530,323 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Efcab10 |
EF-hand calcium binding domain 10 |
|
affects expression |
ISO |
6 |
51,741,044 |
51,747,963 |
RGD:6480464 |
CTD |
| G |
Efhd1 |
EF-hand domain family, member D1 |
|
decreases expression |
ISO |
9 |
86,076,009 |
86,124,552 |
RGD:6480464 |
CTD |
| G |
Efnb2 |
ephrin B2 |
|
increases expression |
EXP |
16 |
86,187,639 |
86,228,023 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
decreases expression |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr3 |
early growth response 3 |
|
increases expression |
EXP |
15 |
50,477,453 |
50,479,909 |
RGD:6480464 |
CTD |
| G |
Egr4 |
early growth response 4 |
|
increases expression |
EXP |
4 |
119,765,289 |
119,767,612 |
RGD:6480464 |
CTD |
| G |
Eif5b |
eukaryotic translation initiation factor 5B |
|
increases expression |
ISO |
9 |
36,937,415 |
36,993,650 |
RGD:6480464 |
CTD |
| G |
Elf1 |
E74-like factor 1 |
|
increases expression |
EXP |
15 |
60,793,794 |
60,835,189 |
RGD:6480464 |
CTD |
| G |
Emr4 |
EGF-like module containing, mucin-like, hormone receptor-like sequence 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
|
decreases expression |
ISO |
15 |
58,555,747 |
58,762,870 |
RGD:6480464 |
CTD |
| G |
Ep300 |
E1A binding protein p300 |
|
multiple interactions |
ISO |
7 |
119,938,507 |
120,008,886 |
RGD:6480464 |
CTD |
| G |
Epb41l1 |
erythrocyte membrane protein band 4.1-like 1 |
|
affects expression |
ISO |
3 |
146,876,451 |
146,944,603 |
RGD:6480464 |
CTD |
| G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
|
affects expression |
ISO |
9 |
108,303,607 |
108,426,942 |
RGD:6480464 |
CTD |
| G |
Epdr1 |
ependymin related protein 1 (zebrafish) |
|
decreases expression |
ISO |
17 |
53,135,000 |
53,160,954 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
decreases expression |
ISO |
15 |
45,497,660 |
45,556,101 |
RGD:6480464 |
CTD |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
increases expression |
ISO |
9 |
66,843,898 |
67,967,970 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
F10 |
coagulation factor X |
|
decreases expression |
ISO |
16 |
81,327,237 |
81,346,544 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
increases expression |
EXP |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
|
increases expression |
EXP |
5 |
149,340,525 |
149,347,268 |
RGD:6480464 |
CTD |
| G |
Fads6 |
fatty acid desaturase 6 |
|
decreases expression |
ISO |
10 |
105,357,799 |
105,373,626 |
RGD:6480464 |
CTD |
| G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
|
decreases expression |
ISO |
7 |
138,246,372 |
138,272,190 |
RGD:6480464 |
CTD |
| G |
Fam126a |
family with sequence similarity 126, member A |
|
decreases expression |
ISO |
4 |
6,500,425 |
6,559,978 |
RGD:6480464 |
CTD |
| G |
Fam198b |
family with sequence similarity 198, member B |
|
decreases expression |
ISO |
2 |
171,368,285 |
171,432,819 |
RGD:6480464 |
CTD |
| G |
Far1 |
fatty acyl CoA reductase 1 |
|
decreases expression |
ISO |
1 |
171,379,992 |
171,437,818 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
affects response to substance |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fat1 |
FAT tumor suppressor homolog 1 (Drosophila) |
|
decreases expression |
EXP |
16 |
50,472,074 |
50,591,399 |
RGD:6480464 |
CTD |
| G |
Fbln2 |
fibulin 2 |
|
decreases expression |
ISO |
4 |
125,380,549 |
125,441,079 |
RGD:6480464 |
CTD |
| G |
Fbxl22 |
F-box and leucine-rich repeat protein 22 |
|
decreases expression |
ISO |
8 |
70,811,502 |
70,818,189 |
RGD:6480464 |
CTD |
| G |
Fcgbp |
Fc fragment of IgG binding protein |
|
increases expression |
ISO |
1 |
83,177,411 |
83,215,268 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
decreases expression |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
decreases expression |
EXP |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
decreases expression |
ISO |
8 |
55,291,396 |
55,310,507 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
decreases expression |
EXP |
8 |
55,291,396 |
55,310,507 |
RGD:6480464 |
CTD |
| G |
Fdxr |
ferredoxin reductase |
|
decreases expression |
ISO |
10 |
105,342,684 |
105,351,374 |
RGD:6480464 |
CTD |
| G |
Fer1l5 |
fer-1-like 5 (C. elegans) |
|
decreases expression |
ISO |
9 |
35,306,132 |
35,358,778 |
RGD:6480464 |
CTD |
| G |
Fer1l5 |
fer-1-like 5 (C. elegans) |
|
decreases expression |
ISO |
9 |
35,306,132 |
35,358,778 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
increases expression |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
multiple interactions |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fibin |
fin bud initiation factor homolog (zebrafish) |
|
increases expression |
EXP |
3 |
95,877,764 |
95,880,035 |
RGD:6480464 |
CTD |
| G |
Fkbp1a |
FK506 binding protein 1a |
|
decreases expression |
ISO |
3 |
141,861,237 |
141,880,797 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
decreases expression |
ISO |
20 |
6,637,478 |
6,686,768 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
decreases expression |
ISO |
20 |
6,637,478 |
6,686,768 |
RGD:6480464 |
CTD |
| G |
Fmo2 |
flavin containing monooxygenase 2 |
|
increases expression |
EXP |
13 |
78,546,315 |
78,592,870 |
RGD:6480464 |
CTD |
| G |
Fmo3 |
flavin containing monooxygenase 3 |
|
increases expression |
EXP |
13 |
78,659,513 |
78,678,524 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxa1 |
forkhead box A1 |
|
affects expression |
ISO |
6 |
77,976,384 |
78,009,176 |
RGD:6480464 |
CTD |
| G |
Foxd4 |
forkhead box D4 |
|
affects expression |
ISO |
1 |
228,348,202 |
228,349,654 |
RGD:6480464 |
CTD |
| G |
Foxj1 |
forkhead box J1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Frmd5 |
FERM domain containing 5 |
|
decreases expression |
ISO |
3 |
108,323,041 |
108,591,163 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
multiple interactions |
ISO |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
increases expression |
ISO |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fshr |
follicle stimulating hormone receptor |
|
decreases expression |
ISO |
6 |
12,925,894 |
13,161,215 |
RGD:6480464 |
CTD |
| G |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor 2 |
|
increases expression |
ISO |
5 |
63,241,397 |
63,611,907 |
RGD:6480464 |
CTD |
| G |
Galnt13 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13) |
|
decreases expression |
ISO |
3 |
36,065,457 |
36,657,842 |
RGD:6480464 |
CTD |
| G |
Galnt7 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) |
|
decreases expression |
ISO |
16 |
35,996,633 |
36,119,925 |
RGD:6480464 |
CTD |
| G |
Gamt |
guanidinoacetate N-methyltransferase |
|
decreases expression |
ISO |
7 |
10,959,990 |
10,962,720 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
multiple interactions |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Gdpd4 |
glycerophosphodiester phosphodiesterase domain containing 4 |
|
increases expression |
ISO |
1 |
155,199,238 |
155,289,511 |
RGD:6480464 |
CTD |
| G |
Gga2 |
golgi associated, gamma adaptin ear containing, ARF binding protein 2 |
|
increases expression |
ISO |
1 |
180,815,366 |
180,848,981 |
RGD:6480464 |
CTD |
| G |
Ggh |
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) |
|
decreases expression |
ISO |
5 |
34,670,883 |
34,693,791 |
RGD:6480464 |
CTD |
| G |
Glrx2 |
glutaredoxin 2 |
|
increases expression |
ISO |
13 |
57,567,017 |
57,589,873 |
RGD:6480464 |
CTD |
| G |
Gm2a |
GM2 ganglioside activator |
|
decreases expression |
ISO |
10 |
40,502,175 |
40,514,708 |
RGD:6480464 |
CTD |
| G |
Gnrhr |
gonadotropin releasing hormone receptor |
|
increases expression |
EXP |
14 |
23,625,135 |
23,656,583 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
decreases expression |
EXP |
19 |
9,629,687 |
9,655,336 |
RGD:6480464 |
CTD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
decreases expression |
ISO |
17 |
47,145,567 |
47,188,345 |
RGD:6480464 |
CTD |
| G |
Gpr141 |
G protein-coupled receptor 141 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
decreases expression |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Grin3b |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
|
decreases expression |
ISO |
7 |
11,243,973 |
11,250,311 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
decreases expression |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gulp1 |
GULP, engulfment adaptor PTB domain containing 1 |
|
decreases expression |
ISO |
9 |
43,660,027 |
43,797,357 |
RGD:6480464 |
CTD |
| G |
Gyltl1b |
glycosyltransferase-like 1B |
|
increases expression |
ISO |
3 |
76,762,507 |
76,768,638 |
RGD:6480464 |
CTD |
| G |
Hace1 |
HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1 |
|
decreases expression |
ISO |
20 |
49,856,040 |
49,973,091 |
RGD:6480464 |
CTD |
| G |
Has2 |
hyaluronan synthase 2 |
|
affects expression |
ISO |
7 |
93,230,135 |
93,256,139 |
RGD:6480464 |
CTD |
| G |
Hccs |
holocytochrome c synthase |
|
decreases expression |
ISO |
X |
45,617,395 |
45,626,790 |
RGD:6480464 |
CTD |
| G |
Hecw2 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 |
|
increases expression |
ISO |
9 |
52,623,951 |
52,839,918 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
increases expression |
ISO |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
decreases expression |
ISO |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
decreases expression |
EXP |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
increases expression |
EXP |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Homer3 |
homer homolog 3 (Drosophila) |
|
decreases expression |
ISO |
16 |
19,617,526 |
19,624,915 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
decreases activity |
ISO |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
decreases activity |
EXP |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
affects expression |
ISO |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
decreases expression |
EXP |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
decreases expression |
ISO |
9 |
63,769,401 |
63,790,622 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
EXP |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ikbkg |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
decreases expression |
ISO |
X |
160,386,558 |
160,420,190 |
RGD:6480464 |
CTD |
| G |
Il16 |
interleukin 16 |
|
decreases expression |
ISO |
1 |
139,908,061 |
140,000,146 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il27ra |
interleukin 27 receptor, alpha |
|
decreases expression |
ISO |
19 |
25,795,355 |
25,807,317 |
RGD:6480464 |
CTD |
| G |
Inha |
inhibin alpha |
|
decreases expression |
EXP |
9 |
74,781,223 |
74,784,124 |
RGD:6480464 |
CTD |
| G |
Insl3 |
insulin-like 3 |
|
decreases expression |
EXP |
16 |
18,890,131 |
18,891,475 |
RGD:6480464 |
CTD |
| G |
Irx3 |
iroquois homeobox 3 |
|
affects expression |
ISO |
19 |
16,345,179 |
16,347,455 |
RGD:6480464 |
CTD |
| G |
Irx5 |
iroquois homeobox 5 |
|
affects expression |
ISO |
19 |
15,747,720 |
15,750,414 |
RGD:6480464 |
CTD |
| G |
Itga3 |
integrin, alpha 3 |
|
decreases expression |
ISO |
10 |
83,728,710 |
83,759,576 |
RGD:6480464 |
CTD |
| G |
Itga3 |
integrin, alpha 3 |
|
decreases expression |
ISO |
10 |
83,728,710 |
83,759,576 |
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
decreases expression |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Jakmip3 |
janus kinase and microtubule interacting protein 3 |
|
decreases expression |
ISO |
1 |
198,793,647 |
198,864,034 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
multiple interactions |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Kalrn |
kalirin, RhoGEF kinase |
|
decreases expression |
ISO |
11 |
68,124,348 |
68,611,336 |
RGD:6480464 |
CTD |
| G |
Kcnab3 |
potassium voltage-gated channel, shaker-related subfamily, beta member 3 |
|
decreases expression |
ISO |
10 |
56,119,461 |
56,126,544 |
RGD:6480464 |
CTD |
| G |
Kcnj16 |
potassium inwardly-rectifying channel, subfamily J, member 16 |
|
decreases expression |
ISO |
10 |
100,514,180 |
100,515,949 |
RGD:6480464 |
CTD |
| G |
Kcnk6 |
potassium channel, subfamily K, member 6 |
|
increases expression |
EXP |
1 |
84,359,738 |
84,367,910 |
RGD:6480464 |
CTD |
| G |
Kif21b |
kinesin family member 21B |
|
increases expression |
ISO |
13 |
49,162,330 |
49,202,704 |
RGD:6480464 |
CTD |
| G |
Kif27 |
kinesin family member 27 |
|
affects expression |
ISO |
17 |
12,230,381 |
12,301,010 |
RGD:6480464 |
CTD |
| G |
Kif5c |
kinesin family member 5C |
|
increases expression |
ISO |
3 |
30,602,210 |
30,755,482 |
RGD:6480464 |
CTD |
| G |
Kif6 |
kinesin family member 6 |
|
increases expression |
ISO |
9 |
6,298,833 |
6,589,880 |
RGD:6480464 |
CTD |
| G |
Kl |
Klotho |
|
decreases expression |
ISO |
12 |
3,732,712 |
3,772,371 |
RGD:6480464 |
CTD |
| G |
Klf10 |
Kruppel-like factor 10 |
|
affects expression |
ISO |
7 |
73,821,190 |
73,826,866 |
RGD:6480464 |
CTD |
| G |
Klf11 |
Kruppel-like factor 11 |
|
affects expression |
ISO |
6 |
42,296,221 |
42,307,925 |
RGD:6480464 |
CTD |
| G |
Kmo |
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
|
decreases expression |
ISO |
13 |
91,363,517 |
91,394,174 |
RGD:6480464 |
CTD |
| G |
Kndc1 |
kinase non-catalytic C-lobe domain (KIND) containing 1 |
|
increases expression |
ISO |
1 |
199,723,472 |
199,750,125 |
RGD:6480464 |
CTD |
| G |
Lbh |
limb bud and heart development |
|
affects expression |
ISO |
6 |
22,662,376 |
22,664,667 |
RGD:6480464 |
CTD |
| G |
Lgals7 |
lectin, galactoside-binding, soluble, 7 |
|
decreases expression |
ISO |
1 |
83,968,263 |
83,970,018 |
RGD:6480464 |
CTD |
| G |
Lgi1 |
leucine-rich, glioma inactivated 1 |
|
increases expression |
ISO |
1 |
242,593,236 |
242,634,141 |
RGD:6480464 |
CTD |
| G |
Lgmn |
legumain |
|
decreases expression |
ISO |
6 |
126,668,905 |
126,694,866 |
RGD:6480464 |
CTD |
| G |
Lgr4 |
leucine-rich repeat-containing G protein-coupled receptor 4 |
|
decreases expression |
ISO |
3 |
95,370,049 |
95,471,040 |
RGD:6480464 |
CTD |
| G |
Lgr5 |
leucine rich repeat containing G protein coupled receptor 5 |
|
affects expression |
ISO |
7 |
54,737,745 |
54,876,664 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
decreases expression |
ISO |
6 |
12,613,622 |
12,651,587 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
decreases expression |
ISO |
6 |
12,613,622 |
12,651,587 |
RGD:6480464 |
CTD |
| G |
Lhpp |
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
|
affects expression |
ISO |
1 |
192,082,902 |
192,174,599 |
RGD:6480464 |
CTD |
| G |
Lima1 |
LIM domain and actin binding 1 |
|
increases expression |
ISO |
7 |
138,519,353 |
138,617,856 |
RGD:6480464 |
CTD |
| G |
Lipg |
lipase, endothelial |
|
decreases expression |
ISO |
18 |
71,795,150 |
71,816,056 |
RGD:6480464 |
CTD |
| G |
Llgl2 |
lethal giant larvae homolog 2 (Drosophila) |
|
increases expression |
ISO |
10 |
105,925,312 |
105,960,550 |
RGD:6480464 |
CTD |
| G |
Loxl2 |
lysyl oxidase-like 2 |
|
decreases expression |
ISO |
15 |
49,982,103 |
50,068,902 |
RGD:6480464 |
CTD |
| G |
Lpcat3 |
lysophosphatidylcholine acyltransferase 3 |
|
decreases expression |
ISO |
4 |
160,786,349 |
160,827,556 |
RGD:6480464 |
CTD |
| G |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
|
affects expression |
ISO |
4 |
128,919,630 |
129,082,488 |
RGD:6480464 |
CTD |
| G |
Lrrc4 |
leucine rich repeat containing 4 |
|
affects expression |
ISO |
4 |
55,698,248 |
55,701,844 |
RGD:6480464 |
CTD |
| G |
Lrrc56 |
leucine rich repeat containing 56 |
|
affects expression |
ISO |
1 |
201,390,131 |
201,404,485 |
RGD:6480464 |
CTD |
| G |
Lrrc66 |
leucine rich repeat containing 66 |
|
decreases expression |
ISO |
14 |
36,977,618 |
37,001,071 |
RGD:6480464 |
CTD |
| G |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
|
decreases expression |
ISO |
9 |
90,278,891 |
90,346,980 |
RGD:6480464 |
CTD |
| G |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
|
decreases expression |
ISO |
6 |
19,942,626 |
20,355,084 |
RGD:6480464 |
CTD |
| G |
Lurap1l |
leucine rich adaptor protein 1-like |
|
increases expression |
EXP |
5 |
99,599,574 |
99,647,041 |
RGD:6480464 |
CTD |
| G |
Ly75 |
lymphocyte antigen 75 |
|
decreases expression |
ISO |
3 |
42,002,053 |
42,088,438 |
RGD:6480464 |
CTD |
| G |
Maff |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
increases expression |
EXP |
7 |
117,328,924 |
117,340,276 |
RGD:6480464 |
CTD |
| G |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) |
|
increases expression |
EXP |
12 |
15,312,420 |
15,323,137 |
RGD:6480464 |
CTD |
| G |
Mageb18 |
melanoma antigen family B, 18 |
|
increases expression |
ISO |
X |
79,444,746 |
79,447,000 |
RGD:6480464 |
CTD |
| G |
Mak |
male germ cell-associated kinase |
|
affects expression |
ISO |
17 |
29,644,795 |
29,698,155 |
RGD:6480464 |
CTD |
| G |
Map1b |
microtubule-associated protein 1B |
|
increases expression |
EXP |
2 |
30,415,235 |
30,508,354 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapkapk3 |
mitogen-activated protein kinase-activated protein kinase 3 |
|
decreases expression |
ISO |
8 |
112,497,626 |
112,531,778 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
increases expression |
ISO |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mbd3l2 |
methyl-CpG binding domain protein 3-like 2 |
|
decreases expression |
ISO |
8 |
15,975,721 |
15,977,070 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
decreases expression |
ISO |
18 |
78,943,608 |
79,057,329 |
RGD:6480464 |
CTD |
| G |
Mdga1 |
MAM domain containing glycosylphosphatidylinositol anchor 1 |
|
decreases expression |
ISO |
20 |
8,149,686 |
8,200,149 |
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
multiple interactions |
ISO |
10 |
86,917,525 |
86,959,080 |
RGD:6480464 |
CTD |
| G |
Mep1b |
meprin 1 beta |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mgst2 |
microsomal glutathione S-transferase 2 |
|
decreases expression |
ISO |
2 |
140,546,939 |
140,568,616 |
RGD:6480464 |
CTD |
| G |
Mixl1 |
Mix paired-like homeobox 1 |
|
increases expression |
ISO |
13 |
96,427,597 |
96,431,628 |
RGD:6480464 |
CTD |
| G |
Mmel1 |
membrane metallo-endopeptidase-like 1 |
|
decreases expression |
ISO |
5 |
171,675,007 |
171,703,353 |
RGD:6480464 |
CTD |
| G |
Mmp19 |
matrix metallopeptidase 19 |
|
decreases expression |
ISO |
7 |
2,091,532 |
2,099,235 |
RGD:6480464 |
CTD |
| G |
Mov10l1 |
Mov10l1, Moloney leukemia virus 10-like 1, homolog (mouse) |
|
decreases expression |
ISO |
7 |
127,293,690 |
127,357,694 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases expression |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mroh2b |
maestro heat-like repeat family member 2B |
|
increases expression |
ISO |
2 |
54,098,254 |
54,118,036 |
RGD:6480464 |
CTD |
| G |
Mt-nd1 |
mitochondrially encoded NADH dehydrogenase 1 |
|
decreases expression |
ISO |
MT |
2,740 |
3,694 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
affects expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mtl5 |
metallothionein-like 5, testis-specific (tesmin) |
|
increases expression |
ISO |
1 |
205,916,071 |
205,934,347 |
RGD:6480464 |
CTD |
| G |
Mtus1 |
microtubule associated tumor suppressor 1 |
|
increases expression |
EXP |
16 |
54,611,502 |
54,664,075 |
RGD:6480464 |
CTD |
| G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
decreases expression |
ISO |
1 |
201,962,340 |
201,997,147 |
RGD:6480464 |
CTD |
| G |
Mvd |
mevalonate (diphospho) decarboxylase |
|
decreases expression |
ISO |
19 |
52,722,306 |
52,732,312 |
RGD:6480464 |
CTD |
| G |
Mybpc2 |
myosin binding protein C, fast-type |
|
increases expression |
ISO |
1 |
94,979,308 |
95,002,804 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
affects localization |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
affects localization |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Mycn |
v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) |
|
decreases expression |
EXP |
6 |
36,508,262 |
36,514,071 |
RGD:6480464 |
CTD |
| G |
Mycn |
v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) |
|
increases expression |
EXP |
6 |
36,508,262 |
36,514,071 |
RGD:6480464 |
CTD |
| G |
Myh8 |
myosin, heavy chain 8, skeletal muscle, perinatal |
|
decreases expression |
ISO |
10 |
53,973,711 |
54,002,442 |
RGD:6480464 |
CTD |
| G |
Myo15a |
myosin XVA |
|
increases expression |
ISO |
10 |
46,742,535 |
46,798,928 |
RGD:6480464 |
CTD |
| G |
Myo7a |
myosin VIIA |
|
decreases expression |
ISO |
1 |
155,292,620 |
155,362,698 |
RGD:6480464 |
CTD |
| G |
Myom3 |
myomesin 3 |
|
increases expression |
ISO |
5 |
154,544,049 |
154,589,658 |
RGD:6480464 |
CTD |
| G |
Nalcn |
sodium leak channel, non-selective |
|
decreases expression |
ISO |
15 |
108,414,286 |
108,658,195 |
RGD:6480464 |
CTD |
| G |
Nbeal2 |
neurobeachin-like 2 |
|
increases expression |
ISO |
8 |
115,005,741 |
115,034,787 |
RGD:6480464 |
CTD |
| G |
Ncan |
neurocan |
|
decreases expression |
ISO |
16 |
19,785,175 |
19,811,651 |
RGD:6480464 |
CTD |
| G |
Ncoa7 |
nuclear receptor coactivator 7 |
|
decreases expression |
ISO |
1 |
27,606,327 |
27,698,608 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
multiple interactions |
ISO |
10 |
48,481,110 |
48,628,538 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
multiple interactions |
ISO |
10 |
48,481,110 |
48,628,538 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated 1 |
|
affects expression |
ISO |
7 |
104,302,038 |
104,344,842 |
RGD:6480464 |
CTD |
| G |
Neb |
nebulin |
|
affects expression |
ISO |
3 |
33,634,963 |
33,833,113 |
RGD:6480464 |
CTD |
| G |
Nek1 |
NIMA-related kinase 1 |
|
increases expression |
ISO |
16 |
32,317,987 |
32,438,010 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 |
|
increases expression |
EXP |
1 |
251,521,559 |
251,527,815 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
|
increases expression |
EXP |
11 |
45,776,027 |
45,811,515 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
increases response to substance |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Noc4l |
nucleolar complex associated 4 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
12 |
46,160,644 |
46,165,182 |
RGD:6480464 |
CTD |
| G |
Npc1l1 |
NPC1-like 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nphp4 |
nephronophthisis 4 |
|
increases expression |
ISO |
5 |
169,711,038 |
169,797,486 |
RGD:6480464 |
CTD |
| G |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
|
decreases expression |
EXP |
X |
73,006,294 |
73,010,422 |
RGD:6480464 |
CTD |
| G |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
|
increases expression |
EXP |
X |
73,006,294 |
73,010,422 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
increases expression |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
decreases expression |
ISO |
7 |
26,189,759 |
26,307,061 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
ISO |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
decreases expression |
ISO |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
decreases expression |
ISO |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
increases expression |
ISO |
3 |
38,866,205 |
38,871,678 |
RGD:6480464 |
CTD |
| G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
|
increases expression |
ISO |
5 |
64,713,468 |
64,753,311 |
RGD:6480464 |
CTD |
| G |
Nrap |
nebulin-related anchoring protein |
|
increases expression |
ISO |
1 |
262,591,454 |
262,672,255 |
RGD:6480464 |
CTD |
| G |
Nrcam |
neuronal cell adhesion molecule |
|
decreases expression |
ISO |
6 |
63,717,460 |
64,015,522 |
RGD:6480464 |
CTD |
| G |
Nrep |
neuronal regeneration related protein |
|
affects expression |
ISO |
18 |
25,842,127 |
25,868,219 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
increases expression |
ISO |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Nrn1 |
neuritin 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nsun7 |
NOP2/Sun domain family, member 7 |
|
decreases expression |
ISO |
14 |
44,556,251 |
44,582,930 |
RGD:6480464 |
CTD |
| G |
Nup210l |
nucleoporin 210-like |
|
decreases expression |
ISO |
2 |
182,328,293 |
182,450,883 |
RGD:6480464 |
CTD |
| G |
Nxf7 |
nuclear RNA export factor 7 |
|
increases expression |
ISO |
X |
122,897,820 |
122,914,925 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
decreases expression |
ISO |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
decreases expression |
EXP |
2 |
31,317,090 |
31,367,485 |
RGD:6480464 |
CTD |
| G |
Otoa |
otoancorin |
|
increases expression |
ISO |
1 |
179,944,477 |
180,013,040 |
RGD:6480464 |
CTD |
| G |
Otog |
otogelin |
|
increases expression |
ISO |
1 |
96,771,215 |
96,840,351 |
RGD:6480464 |
CTD |
| G |
Oxct1 |
3-oxoacid CoA transferase 1 |
|
affects expression |
ISO |
2 |
53,189,358 |
53,217,848 |
RGD:6480464 |
CTD |
| G |
Oxtr |
oxytocin receptor |
|
decreases expression |
ISO |
4 |
148,314,089 |
148,326,797 |
RGD:6480464 |
CTD |
| G |
Pacs1 |
phosphofurin acidic cluster sorting protein 1 |
|
increases expression |
ISO |
1 |
207,750,953 |
207,903,865 |
RGD:6480464 |
CTD |
| G |
Pah |
phenylalanine hydroxylase |
|
increases expression |
ISO |
7 |
24,175,898 |
24,243,592 |
RGD:6480464 |
CTD |
| G |
Parvb |
parvin, beta |
|
decreases expression |
ISO |
7 |
122,223,325 |
122,310,356 |
RGD:6480464 |
CTD |
| G |
Pcolce |
procollagen C-endopeptidase enhancer |
|
decreases expression |
ISO |
12 |
19,672,505 |
19,678,821 |
RGD:6480464 |
CTD |
| G |
Pcsk7 |
proprotein convertase subtilisin/kexin type 7 |
|
decreases expression |
ISO |
8 |
48,879,382 |
48,901,968 |
RGD:6480464 |
CTD |
| G |
Pcyt1a |
phosphate cytidylyltransferase 1, choline, alpha |
|
decreases expression |
ISO |
11 |
70,133,325 |
70,173,686 |
RGD:6480464 |
CTD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP-specific |
|
decreases expression |
ISO |
2 |
40,196,097 |
41,311,012 |
RGD:6480464 |
CTD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP-specific |
|
decreases expression |
ISO |
2 |
40,196,097 |
41,311,012 |
RGD:6480464 |
CTD |
| G |
Pde6c |
phosphodiesterase 6C, cGMP specific, cone, alpha prime |
|
increases expression |
ISO |
1 |
242,459,653 |
242,515,102 |
RGD:6480464 |
CTD |
| G |
Pdilt |
protein disulfide isomerase-like, testis expressed |
|
increases expression |
ISO |
1 |
177,750,348 |
177,782,699 |
RGD:6480464 |
CTD |
| G |
Pdlim2 |
PDZ and LIM domain 2 |
|
decreases expression |
ISO |
15 |
50,564,108 |
50,575,871 |
RGD:6480464 |
CTD |
| G |
Pdzrn4 |
PDZ domain containing RING finger 4 |
|
decreases expression |
ISO |
7 |
131,114,108 |
131,265,328 |
RGD:6480464 |
CTD |
| G |
Per2 |
period circadian clock 2 |
|
increases expression |
ISO |
9 |
90,645,342 |
90,687,509 |
RGD:6480464 |
CTD |
| G |
Per3 |
period circadian clock 3 |
|
increases expression |
ISO |
5 |
168,152,693 |
168,187,442 |
RGD:6480464 |
CTD |
| G |
Pex1 |
peroxisomal biogenesis factor 1 |
|
decreases expression |
ISO |
4 |
27,235,147 |
27,275,076 |
RGD:6480464 |
CTD |
| G |
Phf21b |
PHD finger protein 21B |
|
increases expression |
EXP |
7 |
122,808,454 |
122,879,651 |
RGD:6480464 |
CTD |
| G |
Pik3c2g |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
|
decreases expression |
ISO |
4 |
176,712,201 |
177,074,095 |
RGD:6480464 |
CTD |
| G |
Piwil4 |
piwi-like RNA-mediated gene silencing 4 |
|
decreases expression |
ISO |
8 |
11,491,035 |
11,534,564 |
RGD:6480464 |
CTD |
| G |
Pkhd1 |
polycystic kidney and hepatic disease 1 |
|
increases expression |
ISO |
9 |
18,833,903 |
19,338,716 |
RGD:6480464 |
CTD |
| G |
Pla2g16 |
phospholipase A2, group XVI |
|
increases expression |
ISO |
1 |
210,281,109 |
210,315,280 |
RGD:6480464 |
CTD |
| G |
Plb1 |
phospholipase B1 |
|
decreases expression |
ISO |
6 |
24,196,110 |
24,294,522 |
RGD:6480464 |
CTD |
| G |
Plcb2 |
phospholipase C, beta 2 |
|
decreases expression |
ISO |
3 |
105,203,524 |
105,223,342 |
RGD:6480464 |
CTD |
| G |
Pld1 |
phospholipase D1 |
|
increases expression |
EXP |
2 |
115,306,940 |
115,460,518 |
RGD:6480464 |
CTD |
| G |
Plin2 |
perilipin 2 |
|
affects expression |
ISO |
5 |
105,718,496 |
105,732,817 |
RGD:6480464 |
CTD |
| G |
Plin5 |
perilipin 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pls1 |
plastin 1 |
|
affects expression |
ISO |
8 |
100,825,543 |
100,858,153 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases activity |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases activity |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
affects expression |
EXP |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
increases expression |
EXP |
1 |
95,994,023 |
95,997,080 |
RGD:6480464 |
CTD |
| G |
Ppp1r18 |
protein phosphatase 1, regulatory subunit 18 |
|
affects expression |
ISO |
20 |
3,013,902 |
3,034,973 |
RGD:6480464 |
CTD |
| G |
Ppp1r1a |
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
|
affects expression |
ISO |
7 |
142,428,730 |
142,436,381 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
decreases expression |
EXP |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Prkag3 |
protein kinase, AMP-activated, gamma 3 non-catalytic subunit |
|
increases expression |
ISO |
9 |
74,069,811 |
74,079,055 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
decreases expression |
ISO |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prlr |
prolactin receptor |
|
decreases expression |
ISO |
2 |
59,507,966 |
59,701,221 |
RGD:6480464 |
CTD |
| G |
Prnp |
prion protein |
|
increases expression |
ISO |
3 |
119,676,137 |
119,691,507 |
RGD:6480464 |
CTD |
| G |
Prph |
peripherin |
|
decreases expression |
ISO |
7 |
137,836,152 |
137,839,931 |
RGD:6480464 |
CTD |
| G |
Ptchd2 |
patched domain containing 2 |
|
decreases expression |
ISO |
5 |
165,319,196 |
165,366,774 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
decreases expression |
ISO |
15 |
45,589,222 |
45,717,866 |
RGD:6480464 |
CTD |
| G |
Ptpn18 |
protein tyrosine phosphatase, non-receptor type 18 |
|
increases expression |
ISO |
9 |
33,197,524 |
33,214,470 |
RGD:6480464 |
CTD |
| G |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
|
increases expression |
ISO |
5 |
94,069,724 |
94,286,657 |
RGD:6480464 |
CTD |
| G |
Ptprh |
protein tyrosine phosphatase, receptor type, H |
|
increases expression |
ISO |
1 |
67,960,564 |
68,004,280 |
RGD:6480464 |
CTD |
| G |
Rab20 |
RAB20, member RAS oncogene family |
|
increases expression |
EXP |
16 |
82,871,002 |
82,895,146 |
RGD:6480464 |
CTD |
| G |
Rab27a |
RAB27A, member RAS oncogene family |
|
decreases expression |
ISO |
8 |
77,798,830 |
77,861,090 |
RGD:6480464 |
CTD |
| G |
Rabggta |
Rab geranylgeranyltransferase, alpha subunit |
|
decreases expression |
ISO |
15 |
33,862,275 |
33,868,619 |
RGD:6480464 |
CTD |
| G |
Ranbp17 |
RAN binding protein 17 |
|
increases expression |
ISO |
10 |
18,111,581 |
18,413,103 |
RGD:6480464 |
CTD |
| G |
Rasal1 |
RAS protein activator like 1 (GAP1 like) |
|
decreases expression |
ISO |
12 |
37,047,909 |
37,080,129 |
RGD:6480464 |
CTD |
| G |
Rasgef1c |
RasGEF domain family, member 1C |
|
increases expression |
ISO |
10 |
35,403,239 |
35,470,217 |
RGD:6480464 |
CTD |
| G |
Rasgrf2 |
RAS protein-specific guanine nucleotide-releasing factor 2 |
|
increases expression |
ISO |
2 |
22,113,649 |
22,360,970 |
RGD:6480464 |
CTD |
| G |
Rbbp7 |
retinoblastoma binding protein 7 |
|
affects expression |
ISO |
X |
52,669,703 |
52,688,332 |
RGD:6480464 |
CTD |
| G |
Rbm44 |
RNA binding motif protein 44 |
|
increases expression |
ISO |
9 |
90,372,335 |
90,393,175 |
RGD:6480464 |
CTD |
| G |
Rbmx |
RNA binding motif protein, X-linked |
|
affects expression |
ISO |
X |
142,112,807 |
142,119,267 |
RGD:6480464 |
CTD |
| G |
Recql |
RecQ protein-like (DNA helicase Q1-like) |
|
decreases expression |
ISO |
4 |
179,927,255 |
179,951,742 |
RGD:6480464 |
CTD |
| G |
RGD1309079 |
similar to Ab2-095 |
|
increases expression |
EXP |
8 |
99,571,924 |
99,591,067 |
RGD:6480464 |
CTD |
| G |
RGD1359127 |
similar to RIKEN cDNA 2310011J03 |
|
affects expression |
EXP |
7 |
10,901,594 |
10,903,722 |
RGD:6480464 |
CTD |
| G |
Rgs6 |
regulator of G-protein signaling 6 |
|
decreases expression |
ISO |
6 |
106,470,420 |
106,964,581 |
RGD:6480464 |
CTD |
| G |
Rgs7 |
regulator of G-protein signaling 7 |
|
decreases expression |
ISO |
13 |
90,732,429 |
91,210,368 |
RGD:6480464 |
CTD |
| G |
Rhod |
ras homolog family member D |
|
decreases expression |
ISO |
1 |
207,000,010 |
207,013,945 |
RGD:6480464 |
CTD |
| G |
Rimbp2 |
RIMS binding protein 2 |
|
increases expression |
ISO |
12 |
28,809,987 |
29,012,169 |
RGD:6480464 |
CTD |
| G |
Rims1 |
regulating synaptic membrane exocytosis 1 |
|
increases expression |
ISO |
9 |
21,089,088 |
21,594,679 |
RGD:6480464 |
CTD |
| G |
Rin3 |
Ras and Rab interactor 3 |
|
increases expression |
EXP |
6 |
126,555,387 |
126,665,098 |
RGD:6480464 |
CTD |
| G |
Rnd1 |
Rho family GTPase 1 |
|
increases expression |
EXP |
7 |
137,418,519 |
137,425,590 |
RGD:6480464 |
CTD |
| G |
Rnd3 |
Rho family GTPase 3 |
|
increases expression |
EXP |
3 |
32,101,433 |
32,118,785 |
RGD:6480464 |
CTD |
| G |
Rnf123 |
ring finger protein 123 |
|
decreases expression |
ISO |
8 |
113,319,535 |
113,347,035 |
RGD:6480464 |
CTD |
| G |
Rnf180 |
ring finger protein 180 |
|
decreases expression |
ISO |
2 |
36,186,010 |
36,253,660 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor A |
|
decreases expression |
ISO |
8 |
73,052,282 |
73,817,764 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor A |
|
decreases expression |
ISO |
8 |
73,052,282 |
73,817,764 |
RGD:6480464 |
CTD |
| G |
Rph3a |
rabphilin 3A |
|
increases expression |
ISO |
12 |
36,678,613 |
36,753,316 |
RGD:6480464 |
CTD |
| G |
Rpl23 |
ribosomal protein L23 |
|
affects expression |
ISO |
10 |
86,527,589 |
86,531,549 |
RGD:6480464 |
CTD |
| G |
Rpp25 |
ribonuclease P/MRP 25 subunit |
|
decreases expression |
ISO |
8 |
61,248,740 |
61,250,120 |
RGD:6480464 |
CTD |
| G |
Rrad |
Ras-related associated with diabetes |
|
decreases expression |
ISO |
19 |
272,791 |
275,957 |
RGD:6480464 |
CTD |
| G |
Rragd |
Ras-related GTP binding D |
|
decreases expression |
ISO |
5 |
49,269,195 |
49,304,824 |
RGD:6480464 |
CTD |
| G |
Rsph9 |
radial spoke head 9 homolog (Chlamydomonas) |
|
affects expression |
ISO |
9 |
10,405,162 |
10,425,818 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
decreases expression |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
decreases expression |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Scara3 |
scavenger receptor class A, member 3 |
|
decreases expression |
ISO |
15 |
45,344,539 |
45,377,576 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
decreases expression |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
increases expression |
EXP |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
increases expression |
ISO |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scg3 |
secretogranin III |
|
decreases expression |
ISO |
8 |
80,467,921 |
80,514,192 |
RGD:6480464 |
CTD |
| G |
Scn1a |
sodium channel, voltage-gated, type I, alpha |
|
decreases expression |
ISO |
3 |
48,238,528 |
48,364,143 |
RGD:6480464 |
CTD |
| G |
Scn9a |
sodium channel, voltage-gated, type IX, alpha |
|
increases expression |
ISO |
3 |
48,438,725 |
48,518,893 |
RGD:6480464 |
CTD |
| G |
Sec14l4 |
SEC14-like 4 (S. cerevisiae) |
|
affects expression |
ISO |
14 |
84,666,417 |
84,683,703 |
RGD:6480464 |
CTD |
| G |
Sema3d |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D |
|
decreases expression |
ISO |
4 |
18,641,725 |
18,832,339 |
RGD:6480464 |
CTD |
| G |
Sema4g |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
|
decreases expression |
ISO |
1 |
250,057,504 |
250,068,990 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
decreases expression |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Sgtb |
small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta |
|
decreases expression |
ISO |
2 |
35,031,975 |
35,065,686 |
RGD:6480464 |
CTD |
| G |
Sh3bgr |
SH3 domain binding glutamic acid-rich protein |
|
decreases expression |
ISO |
11 |
36,511,326 |
36,535,444 |
RGD:6480464 |
CTD |
| G |
Sh3rf1 |
SH3 domain containing ring finger 1 |
|
increases expression |
EXP |
16 |
32,054,773 |
32,215,987 |
RGD:6480464 |
CTD |
| G |
Shkbp1 |
Sh3kbp1 binding protein 1 |
|
decreases expression |
ISO |
1 |
82,422,792 |
82,436,208 |
RGD:6480464 |
CTD |
| G |
Si |
sucrase-isomaltase (alpha-glucosidase) |
|
decreases expression |
ISO |
2 |
163,520,975 |
163,601,280 |
RGD:6480464 |
CTD |
| G |
Six2 |
SIX homeobox 2 |
|
affects expression |
ISO |
6 |
9,094,655 |
9,097,973 |
RGD:6480464 |
CTD |
| G |
Slc10a7 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 7 |
|
decreases expression |
ISO |
19 |
31,029,928 |
31,074,346 |
RGD:6480464 |
CTD |
| G |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
|
decreases expression |
ISO |
11 |
68,934,104 |
69,087,168 |
RGD:6480464 |
CTD |
| G |
Slc13a1 |
solute carrier family 13 (sodium/sulfate symporters), member 1 |
|
increases expression |
ISO |
4 |
50,460,176 |
50,537,659 |
RGD:6480464 |
CTD |
| G |
Slc25a30 |
solute carrier family 25, member 30 |
|
decreases expression |
ISO |
15 |
56,656,204 |
56,695,237 |
RGD:6480464 |
CTD |
| G |
Slc25a38 |
solute carrier family 25, member 38 |
|
affects expression |
ISO |
8 |
125,084,481 |
125,097,326 |
RGD:6480464 |
CTD |
| G |
Slc26a3 |
solute carrier family 26, member 3 |
|
decreases expression |
ISO |
6 |
49,305,008 |
49,346,008 |
RGD:6480464 |
CTD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
increases expression |
EXP |
16 |
18,769,909 |
18,786,988 |
RGD:6480464 |
CTD |
| G |
Slc35d2 |
solute carrier family 35, member D2 |
|
decreases expression |
ISO |
17 |
6,515,164 |
6,546,280 |
RGD:6480464 |
CTD |
| G |
Slc38a11 |
solute carrier family 38, member 11 |
|
increases expression |
ISO |
3 |
47,186,809 |
47,306,376 |
RGD:6480464 |
CTD |
| G |
Slc4a10 |
solute carrier family 4, sodium bicarbonate transporter, member 10 |
|
decreases expression |
ISO |
3 |
43,979,103 |
44,274,283 |
RGD:6480464 |
CTD |
| G |
Slc5a11 |
solute carrier family 5 (sodium/glucose cotransporter), member 11 |
|
increases expression |
ISO |
1 |
182,094,600 |
182,133,640 |
RGD:6480464 |
CTD |
| G |
Slc5a4 |
solute carrier family 5 (low affinity glucose cotransporter), member 4 |
|
decreases expression |
ISO |
20 |
12,876,032 |
12,919,116 |
RGD:6480464 |
CTD |
| G |
Slc5a9 |
solute carrier family 5 (sodium/glucose cotransporter), member 9 |
|
increases expression |
ISO |
5 |
133,455,811 |
133,465,217 |
RGD:6480464 |
CTD |
| G |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
|
decreases expression |
ISO |
19 |
15,098,281 |
15,139,898 |
RGD:6480464 |
CTD |
| G |
Slco6b1 |
solute carrier organic anion transporter family, member 6b1 |
|
increases expression |
ISO |
9 |
96,130,052 |
96,211,483 |
RGD:6480464 |
CTD |
| G |
Slit1 |
slit homolog 1 (Drosophila) |
|
decreases expression |
ISO |
1 |
246,813,909 |
246,964,408 |
RGD:6480464 |
CTD |
| G |
Slit3 |
slit homolog 3 (Drosophila) |
|
decreases expression |
ISO |
10 |
19,983,166 |
20,576,689 |
RGD:6480464 |
CTD |
| G |
Smad7 |
SMAD family member 7 |
|
affects expression |
ISO |
18 |
72,294,803 |
72,323,354 |
RGD:6480464 |
CTD |
| G |
Soat2 |
sterol O-acyltransferase 2 |
|
decreases expression |
ISO |
7 |
140,890,902 |
140,903,999 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sorbs2 |
sorbin and SH3 domain containing 2 |
|
decreases expression |
ISO |
16 |
49,722,539 |
49,917,550 |
RGD:6480464 |
CTD |
| G |
Sorbs2 |
sorbin and SH3 domain containing 2 |
|
decreases expression |
ISO |
16 |
49,722,539 |
49,917,550 |
RGD:6480464 |
CTD |
| G |
Spag1 |
sperm associated antigen 1 |
|
decreases expression |
ISO |
7 |
71,699,341 |
71,759,373 |
RGD:6480464 |
CTD |
| G |
Spry4 |
sprouty homolog 4 (Drosophila) |
|
increases expression |
EXP |
18 |
31,532,680 |
31,547,586 |
RGD:6480464 |
CTD |
| G |
Spta1 |
spectrin, alpha, erythrocytic 1 (elliptocytosis 2) |
|
increases expression |
ISO |
13 |
89,951,924 |
90,028,592 |
RGD:6480464 |
CTD |
| G |
Sptbn2 |
spectrin, beta, non-erythrocytic 2 |
|
increases expression |
ISO |
1 |
207,318,258 |
207,358,896 |
RGD:6480464 |
CTD |
| G |
Sptbn4 |
spectrin, beta, non-erythrocytic 4 |
|
increases expression |
ISO |
1 |
82,436,626 |
82,523,827 |
RGD:6480464 |
CTD |
| G |
Sptbn5 |
spectrin, beta, non-erythrocytic 5 |
|
decreases expression |
ISO |
3 |
106,548,449 |
106,591,064 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
increases expression |
ISO |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
|
increases expression |
ISO |
7 |
120,522,511 |
120,580,212 |
RGD:6480464 |
CTD |
| G |
Sstr1 |
somatostatin receptor 1 |
|
increases expression |
ISO |
6 |
78,803,393 |
78,806,978 |
RGD:6480464 |
CTD |
| G |
St8sia5 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
|
decreases expression |
ISO |
18 |
74,163,989 |
74,224,969 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
affects expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases activity |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Stc1 |
stanniocalcin 1 |
|
increases expression |
EXP |
15 |
49,566,885 |
49,577,539 |
RGD:6480464 |
CTD |
| G |
Stxbp6 |
syntaxin binding protein 6 (amisyn) |
|
increases expression |
EXP |
6 |
64,249,917 |
64,490,471 |
RGD:6480464 |
CTD |
| G |
Susd3 |
sushi domain containing 3 |
|
decreases expression |
EXP |
17 |
21,359,497 |
21,375,693 |
RGD:6480464 |
CTD |
| G |
Susd3 |
sushi domain containing 3 |
|
increases expression |
EXP |
17 |
21,359,497 |
21,375,693 |
RGD:6480464 |
CTD |
| G |
Taf1 |
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
increases expression |
ISO |
X |
89,590,556 |
89,666,569 |
RGD:6480464 |
CTD |
| G |
Tdrd9 |
tudor domain containing 9 |
|
increases expression |
ISO |
6 |
136,758,888 |
136,876,987 |
RGD:6480464 |
CTD |
| G |
Tecrl |
trans-2,3-enoyl-CoA reductase-like |
|
decreases expression |
ISO |
14 |
26,619,939 |
26,693,786 |
RGD:6480464 |
CTD |
| G |
Tgm1 |
transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) |
|
increases expression |
ISO |
15 |
33,846,367 |
33,859,615 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
increases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
decreases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
decreases expression |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
decreases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
decreases expression |
EXP |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tle2 |
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
|
decreases expression |
ISO |
7 |
9,592,238 |
9,607,487 |
RGD:6480464 |
CTD |
| G |
Tll2 |
tolloid-like 2 |
|
decreases expression |
ISO |
1 |
246,259,524 |
246,406,825 |
RGD:6480464 |
CTD |
| G |
Tm7sf2 |
transmembrane 7 superfamily member 2 |
|
decreases expression |
ISO |
1 |
208,700,770 |
208,705,093 |
RGD:6480464 |
CTD |
| G |
Tmed5 |
transmembrane emp24 protein transport domain containing 5 |
|
decreases expression |
ISO |
14 |
2,155,594 |
2,167,280 |
RGD:6480464 |
CTD |
| G |
Tmem145 |
transmembrane protein 145 |
|
increases expression |
ISO |
1 |
80,580,829 |
80,590,503 |
RGD:6480464 |
CTD |
| G |
Tmem37 |
transmembrane protein 37 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tmem62 |
transmembrane protein 62 |
|
decreases expression |
ISO |
3 |
107,752,430 |
107,786,727 |
RGD:6480464 |
CTD |
| G |
Tmem71 |
transmembrane protein 71 |
|
decreases expression |
ISO |
7 |
103,883,566 |
103,931,188 |
RGD:6480464 |
CTD |
| G |
Tmem86a |
transmembrane protein 86A |
|
decreases expression |
ISO |
1 |
97,604,511 |
97,608,861 |
RGD:6480464 |
CTD |
| G |
Tmprss15 |
transmembrane protease, serine 15 |
|
decreases expression |
ISO |
11 |
18,017,213 |
18,167,545 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11a |
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
|
increases expression |
ISO |
13 |
11,958,002 |
12,014,371 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
decreases expression |
ISO |
10 |
12,940,334 |
12,942,343 |
RGD:6480464 |
CTD |
| G |
Tns3 |
tensin 3 |
|
decreases expression |
ISO |
14 |
88,999,003 |
89,182,348 |
RGD:6480464 |
CTD |
| G |
Tnxb |
tenascin XB |
|
decreases expression |
ISO |
20 |
4,133,875 |
4,178,049 |
RGD:6480464 |
CTD |
| G |
Tnxb |
tenascin XB |
|
decreases expression |
ISO |
20 |
4,133,875 |
4,178,049 |
RGD:6480464 |
CTD |
| G |
Tox3 |
TOX high mobility group box family member 3 |
|
affects expression |
ISO |
19 |
17,945,550 |
17,975,738 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases activity |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53inp2 |
tumor protein p53 inducible nuclear protein 2 |
|
decreases expression |
ISO |
3 |
145,878,005 |
145,886,088 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
increases expression |
EXP |
8 |
71,331,304 |
71,358,063 |
RGD:6480464 |
CTD |
| G |
Tpst2 |
tyrosylprotein sulfotransferase 2 |
|
decreases expression |
ISO |
19 |
14,283,684 |
14,297,517 |
RGD:6480464 |
CTD |
| G |
Trim54 |
tripartite motif-containing 54 |
|
increases expression |
ISO |
6 |
25,218,008 |
25,237,575 |
RGD:6480464 |
CTD |
| G |
Trim6 |
tripartite motif containing 6 |
|
affects expression |
ISO |
1 |
162,059,220 |
162,094,672 |
RGD:6480464 |
CTD |
| G |
Trim6 |
tripartite motif containing 6 |
|
affects expression |
ISO |
1 |
162,059,220 |
162,094,672 |
RGD:6480464 |
CTD |
| G |
Tssc4 |
tumor suppressing subtransferable candidate 4 |
|
decreases expression |
ISO |
1 |
203,344,569 |
203,346,200 |
RGD:6480464 |
CTD |
| G |
Ttc25 |
tetratricopeptide repeat domain 25 |
|
affects expression |
ISO |
10 |
89,488,575 |
89,516,858 |
RGD:6480464 |
CTD |
| G |
Ttn |
titin |
|
increases expression |
ISO |
3 |
59,404,023 |
59,665,308 |
RGD:6480464 |
CTD |
| G |
Ttn |
titin |
|
increases expression |
ISO |
3 |
59,404,023 |
59,665,308 |
RGD:6480464 |
CTD |
| G |
Ttyh2 |
tweety homolog 2 (Drosophila) |
|
decreases expression |
ISO |
10 |
104,553,284 |
104,596,673 |
RGD:6480464 |
CTD |
| G |
Tubb6 |
tubulin, beta 6 class V |
|
decreases expression |
ISO |
18 |
63,919,776 |
63,929,415 |
RGD:6480464 |
CTD |
| G |
Txk |
TXK tyrosine kinase |
|
increases expression |
EXP |
14 |
37,867,565 |
37,923,075 |
RGD:6480464 |
CTD |
| G |
Txndc2 |
thioredoxin domain containing 2 (spermatozoa) |
|
decreases expression |
ISO |
9 |
104,391,636 |
104,396,147 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
affects expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Uap1l1 |
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
|
affects expression |
ISO |
3 |
3,526,396 |
3,531,669 |
RGD:6480464 |
CTD |
| G |
Ubqlnl |
ubiquilin-like |
|
decreases expression |
ISO |
1 |
161,984,944 |
161,987,193 |
RGD:6480464 |
CTD |
| G |
Ulk1 |
Unc-51 like kinase 1 (C. elegans) |
|
decreases expression |
ISO |
12 |
45,996,251 |
46,022,505 |
RGD:6480464 |
CTD |
| G |
Unc13d |
unc-13 homolog D (C. elegans) |
|
decreases expression |
ISO |
10 |
106,170,475 |
106,185,215 |
RGD:6480464 |
CTD |
| G |
Ush1c |
Usher syndrome 1C |
|
increases expression |
ISO |
1 |
96,720,185 |
96,768,550 |
RGD:6480464 |
CTD |
| G |
Ush1c |
Usher syndrome 1C |
|
increases expression |
ISO |
1 |
96,720,185 |
96,768,550 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
decreases expression |
EXP |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Wdr6 |
WD repeat domain 6 |
|
affects expression |
ISO |
8 |
113,618,341 |
113,624,757 |
RGD:6480464 |
CTD |
| G |
Wnk2 |
WNK lysine deficient protein kinase 2 |
|
increases expression |
ISO |
17 |
21,461,980 |
21,600,361 |
RGD:6480464 |
CTD |
| G |
Wnt8a |
wingless-type MMTV integration site family, member 8A |
|
affects expression |
ISO |
18 |
27,007,156 |
27,012,749 |
RGD:6480464 |
CTD |
| G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
|
increases expression |
EXP |
8 |
51,931,530 |
52,094,813 |
RGD:6480464 |
CTD |
| G |
Zc3h12a |
zinc finger CCCH type containing 12A |
|
increases expression |
EXP |
5 |
144,457,753 |
144,467,275 |
RGD:6480464 |
CTD |
| G |
Zfat |
zinc finger and AT hook domain containing |
|
decreases expression |
ISO |
7 |
105,570,121 |
105,736,965 |
RGD:6480464 |
CTD |
| G |
Zfp185 |
zinc finger protein 185 |
|
affects expression |
ISO |
X |
158,990,740 |
159,024,426 |
RGD:6480464 |
CTD |
| G |
Zfp27 |
zinc finger protein 27 |
|
decreases expression |
ISO |
1 |
84,910,957 |
84,914,508 |
RGD:6480464 |
CTD |
| G |
Zfp36 |
zinc finger protein 36 |
|
increases expression |
EXP |
1 |
83,486,643 |
83,489,123 |
RGD:6480464 |
CTD |
| G |
Zfp52 |
zinc finger protein 52 |
|
decreases expression |
ISO |
1 |
59,540,774 |
59,568,607 |
RGD:6480464 |
CTD |
| G |
Zfp771 |
zinc finger protein 771 |
|
affects expression |
ISO |
1 |
186,506,270 |
186,517,652 |
RGD:6480464 |
CTD |
Term paths to the root
|